Protective Provisions. 10.1 Approval of Series A Preference Shares, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in addition to any other vote or consent required elsewhere in the Memorandum and Articles or by applicable Law, the Company shall not, and Members of the Company shall procure that the Company and each of its Subsidiaries shall not (directly or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take any of the following actions (other than those in connection with a Non-Liquidation M&A) without the prior vote or written consent of the holders of at least 50% of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately as a single class. (a) to liquidate, dissolve or wind up the affairs of the Company, or effect any Liquidating Transaction; (b) to amend, alter, or repeal any provision of the Memorandum and Articles; (c) to create or authorize the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, or increase the authorized number of shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015; (d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement); (e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015; (f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director; (g) to increase or decrease the size of the Board; (h) to approve any change in the business scope or activities of the Company; (i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing; (j) to approve and change any compensation package of the management of the Company, including but not limited to the chief executive officer, general manager, and any other key employee; and (k) to agree or undertake to do any of the foregoing.
Appears in 2 contracts
Sources: Shareholder Agreement, Shareholder Agreement (iClick Interactive Asia Group LTD)
Protective Provisions. 10.1 Approval of Series A Preference SharesThe Partnership and the General Partner hereby covenant and agree that, Series B Preference Shares, Series D Preference Shares. For so for as long as Bertelsmannany Preferred Units are outstanding, Sumitomo and BlueFocus respectively holds no less than 448,801 Sharesneither the Partnership nor the General Partner shall, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events)Partnership and the General Partner shall cause their respective Subsidiaries not to, in addition to any other vote undertake or consent required elsewhere in the Memorandum and Articles or by applicable Law, the Company shall not, and Members of the Company shall procure that the Company and each of its Subsidiaries shall not (directly or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take permit any of the following actions (other than those in connection with a Non-Liquidation M&A) actions, directly or indirectly, without the prior vote or written consent of the holders of at least 50% of the then outstanding Series D Preference Shares, the holders record of at least 50% a majority of the Preferred Units then outstanding Series B Preference Shares and outstanding:
(1) in the holders of at least 50% case of the then outstanding Series A Preference SharesPartnership, each voting separately as a single class.
(a) to liquidate, dissolve authorize or wind up the affairs of the Company, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum and Articles;
(c) to create or authorize the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Sharesissue, or increase the authorized number or issued amount of, (A) equity securities ranking, as to distributions and upon liquidation, on a parity with or senior to the Preferred Units or (B) Common Units or other equity securities ranking, as to distributions and upon liquidation, junior to the Preferred Units, to the extent that such Common Units or other junior equity securities contain any rights that restrict in any way management of the Partnership, the General Partner or their respective Subsidiaries or would reasonably be expected to interfere with the Preferred Units or the rights of the holders thereof; and (2) in the case of the General Partner, any Subsidiary of the General Partner or any Subsidiary of the Partnership, authorize or issue additional (A) shares of preferred stock or preferred equity securities or (B) shares of common stock or common equity securities or other equity securities ranking, as to distributions and upon liquidation, junior to shares of such entity's preferred stock or preferred equity securities, to the extent that such shares of common stock, common equity securities or other junior equity securities contain any rights that restrict in any way management of the General Partner, the Partnership or their respective Subsidiaries or would reasonably be expected to interfere with the Preferred Units or the rights of the holders thereof;
(ii) amend, alter, repeal or waive any of the provisions of (1) this Amendment or the Purchase Agreement or (2) the certificate of limited partnership of the Partnership, the Partnership Agreement, the Articles of Incorporation or bylaws of the General Partner or the organizational documents of any of their respective Subsidiaries, in the case of clause (2) only, to the extent that such amendment would reasonably be expected to adversely affect the Preferred Units or the rights of the holders thereof;
(iii) redeem, purchase or otherwise acquire for any consideration (1) in the case of the Partnership, equity securities of the Partnership that rank, as to distributions and upon liquidation, junior to the Preferred Units, including Common Units, and (2) in the case of the General Partner, any Subsidiary of the General Partner or any Subsidiary of the Partnership, any class or series of capital stock or equity securities; provided, that the foregoing shall not prohibit the following: (A) redemptions pursuant to the Share Redemption Program; and (B) redemptions of Common Units in exchange for which the General Partner issues REIT Shares to the holders of such Common Units as the sole consideration therefor pursuant to the terms of the Partnership Agreement;
(iv) engage in a Change of Control;
(v) commence or suffer to exist an Event of Bankruptcy as to the Partnership, the General Partner or any of their respective Subsidiaries;
(vi) pay any special distributions (which, for purposes hereof, shall mean any distribution other than a distribution made on a regular monthly basis consistent with past practice) on (1) in the case of the Partnership, Common Units or other equity securities that rank, as to distributions and upon liquidation, junior to the Preferred Units and (2) in the case of the General Partner, any Subsidiary of the General Partner or any Subsidiary of the Partnership, shares of common stock or common equity securities or other equity securities that rank, as to distributions and upon liquidation, junior to such entity's shares of preferred stock or preferred equity securities; provided, that the foregoing shall not prohibit (A) special distributions that are necessary to preserve the General Partner's status as a REIT under the Code; and (B) distributions to the General Partner's stockholders paid in shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;General Partner's common stock; or
(dvii) to createengage in a recapitalization, reorganization, merger, unit or stock split, statutory unit or stock exchange, sale of all or substantially all of such entity's assets, tender offer for all or substantially all of its Common Units, shares of common stock or other common equity securities, as the case may be, or issue of any debenture or any obligation convertible intoother similar transaction. Neither the Partnership nor the General Partner shall take, and shall cause their respective Subsidiaries not to take, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares action in furtherance of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package of the management of the Company, including but not limited to the chief executive officer, general manager, and any other key employee; and
(k) to agree or undertake to do any of the foregoingforegoing actions without obtaining the required consent therefor, as specified in this Section 7(a). Notwithstanding any provision in this Section 7(a) to the contrary, the Partnership shall be able to enter into tax protection agreements in the ordinary course of its business.
Appears in 1 contract
Sources: Limited Partnership Agreement (Griffin Capital Essential Asset REIT II, Inc.)
Protective Provisions. 10.1 Approval At any time when shares of Series A Preference SharesPreferred Stock are outstanding (provided, that, if a Mandatory Redemption Notice has been given, and any shares of Series B Preference SharesA Preferred Stock thereafter remain outstanding, or on and after a Redemption Failure, all shares of Series D Preference Shares. For so long as BertelsmannA Preferred Stock which have been redeemed, Sumitomo if any, shall for purposes of determining whether either of the conditions set forth in this sentence are met, be deemed outstanding) and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares convertible into shares of Common Stock equal to at least ten percent (subject to adjustments made for share split, subdivision, consolidation, reorganization and 10.0%) of the like eventsvoting power of the Corporation’s Common Stock (on a fully diluted basis), or at any time when the Requisite Investors collectively hold at least thirty-three percent (33.0%) of the aggregate amount of Series A Preferred Stock issued to the Requisite Investors on the Original Issuance Date, the Corporation shall not, and shall not permit any of its subsidiaries to, and neither the Corporation nor any subsidiary shall enter into any agreement to, either directly or indirectly, by amendment, merger, consolidation or otherwise, do any of the following without (in addition to any other vote required by law or consent required elsewhere in this Certificate of Incorporation) the Memorandum and Articles or by applicable Law, the Company shall not, and Members of the Company shall procure that the Company and each of its Subsidiaries shall not (directly or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take any of the following actions (other than those in connection with a Non-Liquidation M&A) without the prior vote or written consent or affirmative vote of the holders of at least 50% a majority of the then outstanding Series D Preference Shares, the holders shares of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference SharesPreferred Stock given in writing or by vote at a meeting, each consenting or voting (as the case may be) separately as a single class., and any such act or transaction entered into without such consent or vote shall be null and void ab initio, and of no force or effect:
(a) to i. liquidate, dissolve or wind wind-up the business and affairs of the CompanyCorporation or any operating subsidiary, effect any merger, consolidation or Deemed Liquidation Event of the Corporation or any operating subsidiary of the Corporation or consummate or agree to make any sale, transfer, assignment, pledge, lease, license, acquisition (other than the acquisition of a Person, business or interest therein, whether by acquisition of assets or securities, merger, consolidation, joint venture, business combination or otherwise, that has positive consolidated earnings, before interest, taxes, depreciation and amortization (each of the foregoing calculated in accordance with U.S. generally accepted accounting principles consistently applied) for the twelve calendar month period ending with the last full calendar month immediately preceding the calculation thereof, and in which shares of Common Stock, Options or Convertible Securities issued to such third party (or its equity holders) as acquisition consideration, if any, represent less than ten percent (10.0%) of the Corporation’s then outstanding Common Stock (on a fully diluted basis)), or effect similar transaction by which the Corporation or any Liquidating Transaction;subsidiary of the Corporation grants on an exclusive basis any rights to any of the Corporation’s or any of a Corporation’s subsidiary’s intellectual property, or consent to any of the foregoing, except for a Deemed Liquidation Event in which the holders of Series A Preferred Stock shall indefeasibly receive for each of their shares of Series A Preferred Stock upon the consummation thereof, an amount in cash not less than the Redemption Price (provided, however, that in no event, irrespective of whether consent is given under this subsection i, shall the Corporation be relieved of, nor shall the holders of Series A Preferred Stock be deemed to have waived, the Corporation’s obligation to redeem all outstanding shares of Series A Preferred Stock and pay the Redemption Price in accordance with Section A.3.c); 1 Insert closing bid price of I.D. Systems, Inc.’s common stock on the last trading day immediately prior to the Original Issuance Date.
(b) to ii. amend, alter, alter or repeal any provision of this Certificate of Incorporation or Bylaws in a manner that adversely affects the Memorandum and Articlespowers, preferences or rights of the Series A Preferred Stock, it being understood that the authorization, issuance, conversion, reclassification, exchange or amendment of a new or existing class or series of capital stock that is, or that is convertible into, capital stock that is pari passu or senior to the powers, privileges, preferences, rights or otherwise, of the Series A Preferred Stock shall be deemed to adversely affect the powers, preferences or rights of the Series A Preferred Stock;
(ca) to create (i) create, or authorize the creation of of, or issue or obligate itself to issue shares of, any other security convertible into additional class or exercisable for any equity security, having rights, preferences or privileges senior series of capital stock of the Corporation unless the same (x) ranks junior to or on parity with the Series A Preference SharesPreferred Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation or upon a Deemed Liquidation Event, the payment of dividends and rights of redemption and (y) is issued at fair market value as reasonably and in good faith determined by the Board, or (ii) increase the authorized number of shares of Series B Preference Shares or the Series D Preference Shares, A Preferred Stock (except as provided in Section A.5.c.i) or increase the authorized number of shares of any additional class or series of capital stock of the Corporation, unless the same ranks junior to the Series A Preference SharesPreferred Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation or upon a Deemed Liquidation Event, the payment of dividends and rights of redemption or (b) create, or authorize the creation of, or issue or obligate itself to issue shares of, any additional class or series of capital stock of any subsidiary of the Corporation;
iv. [intentionally omitted];
v. purchase or redeem (or permit any subsidiary to purchase or redeem) or pay, declare or set aside any fund for, any dividend or distribution on, any Junior Stock, other than purchases of Equity Securities upon the termination of an employee of the Corporation or any of its subsidiaries in accordance with the terms of such employee’s employment agreement or any equity incentive or similar plan approved by the Board;
vi. issue any shares of Series B Preference Shares A Preferred Stock to any individual, entity or other person other than to the Series D Preference Shares Requisite Investors, and any transferees thereof;
vii. create, incur, grant, enter into, permit, assume or do suffer to exist, directly or indirectly, (i) any act which indebtedness by the Corporation (or any of its subsidiaries) or otherwise issue any Debt Securities at any time when, or as a result of which, the principal amount of the Corporation’s total outstanding and available indebtedness and Debt Securities exceeds the product of (x) three (3) multiplied by (y) the consolidated earnings, before interest, taxes, depreciation and amortization of the Corporation and its subsidiaries (each of the foregoing calculated in accordance with U.S. generally accepted accounting principles) for the twelve calendar month period ending with the last full calendar month immediately preceding the calculation thereof, (ii) any lien, charge or other encumbrance on any of the Corporation’s (or any of its subsidiaries’) properties or assets other than Permitted Liens (as defined in the Purchase Agreement), or (iii) guaranty the obligations of any third party;
viii. take any actions to, or that has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Sharesa, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) change in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board to a number other than seven (7) directors;
ix. take any actions to relocate, or relocate, the principal executive offices of the Corporation outside of the United States;
x. enter into any arrangement with any Affiliate or Associate of the Corporation or any subsidiary of the Corporation, or modify any existing arrangement between the Corporation and any of its Affiliates or Associates or an existing arrangement between any subsidiary of the Corporation and any of its Affiliates or Associates, except for transactions (x) solely between or among two or more of the Corporation and any of its wholly-owned subsidiaries or (y) the terms and conditions of which have been determined by the Board to be no less favorable in any material respect to the Corporation or any subsidiary of the Corporation than those terms and conditions that would be obtained on an arm’s length basis and that does not provide for, or is not reasonably likely to result in, aggregate payments to or by the Corporation or any subsidiary of the Corporation in excess of $1,000,000; provided that the provisions of this subsection x shall not apply to customary director, officer, employee and consultant compensation (including bonuses) and other employment benefits (including retirement, health, stock and other benefit plans) and indemnification and insurance arrangements approved by the Board;
(h) to approve xi. take any change in the business scope actions to, or activities otherwise, amend, modify, repeal or enter any waiver of the Company;[_]2, or enter into or consummate any replacement, substitution or refinancing thereof; or
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financingxii. agree to, the Series B financing commit to, resolve to, or the Series D financing;
(j) to approve and change otherwise enter into any compensation package of the management of the Company, including but not limited to the chief executive officer, general manager, and any other key employee; and
(k) to agree or undertake agreement to do any of the foregoing. For the avoidance of doubt, any action that is permitted under one or more of the above subsections i-xii of this Section A.4.c, but is not permitted under any other of such subsections shall nevertheless require consent as described in this Section A.4.c under such other subsections.
Appears in 1 contract
Sources: Investment and Transaction Agreement (Id Systems Inc)
Protective Provisions. 10.1 Approval Until the earlier of (x) the date on which less than 25% of the shares of Series A Preference SharesB1/B2/B3/B4 Preferred Stock are outstanding after the applicable Initial Issue Date of the Series B1/B2/B3/B4 Preferred Stock, (y) the Series B1 Transition Date, Series B Preference SharesB2 Transition Date, Series D Preference Shares. For so long B3 Transition Date, or the Series B4 Transition Date, as Bertelsmann, Sumitomo the case may be and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and z) the like events), in addition to any other vote or consent required elsewhere in the Memorandum and Articles or by applicable Laweffective date of a Deemed Liquidation, the Company Corporation shall not, and Members of the Company shall procure that the Company and each not permit any of its Subsidiaries shall not (to, directly or indirectly, without the affirmative vote (or written consent as permitted by amendmentthe DGCL, the Certificate of Incorporation and Bylaws) of the Requisite Holders, voting (or consenting) as a separate class:
(i) amend, alter, modify or repeal (whether by merger, consolidation, amalgamation, scheme of arrangement consolidation or otherwise) take this Certificate of Designations, the Certificate of Incorporation or the Bylaws in any manner that adversely affects the rights, preferences, privileges or the restrictions provided for the benefit of, the Series B1/B2/B3/B4 Preferred Stock;
(ii) authorize, create, designate, issue or sell any (A) class or series of capital stock (including shares of treasury stock) that would be classified as Senior Securities or Parity Securities or (B) rights, options, warrants or other securities (including debt securities) convertible into or exercisable or exchangeable for capital stock or any equity security or having any other equity feature, in each case, that would be classified as either Senior Securities or Parity Securities, except as pursuant to the conversion or exercise of securities issued and outstanding as of the Initial Issue Date of the Series B1 Preferred Stock or pursuant to any agreement in effect on or prior to the Initial Issue Date of the Series B1 Preferred Stock;
(iii) purchase or redeem (or permit any subsidiary to purchase or redeem) or pay or declare any dividend, or make any distribution on, any shares of capital stock of the Corporation, other than redemptions of or dividends or distributions on the Series B1/B2/B3/B4 Preferred Stock as expressly authorized herein; or
(iv) enter into any agreement to do any of the following actions (other than those in connection with a Non-Liquidation M&A) without foregoing that is not expressly made conditional on obtaining the prior affirmative vote or written consent of the holders of at least 50% of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately as a single classRequisite Holders.
(a) to liquidate, dissolve or wind up the affairs of the Company, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum and Articles;
(c) to create or authorize the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, or increase the authorized number of shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package of the management of the Company, including but not limited to the chief executive officer, general manager, and any other key employee; and
(k) to agree or undertake to do any of the foregoing.
Appears in 1 contract
Sources: Securities Purchase Agreement (Idera Pharmaceuticals, Inc.)
Protective Provisions. 10.1 Acts of the Group Companies Requiring Approval of Series A Preference Shares, Preferred Holders and Series B Preference SharesPreferred Holders. Regardless of anything else contained herein or in the Charter Documents of any Group Company, Series D Preference Shares. For so long as Bertelsmannno Group Company shall take, Sumitomo permit to occur, approve, authorize, or agree or commit to do any of the following, and BlueFocus respectively holds no less than 448,801 SharesParty shall permit any Group Company to, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in addition to any other vote or consent required elsewhere in the Memorandum and Articles or by applicable Law, the Company shall not, and Members shareholders of the Company shall procure that not permit the Company and each to take, permit to occur, approve, authorize, or agree or commit to do any of its Subsidiaries shall not (the following, whether in a single transaction or a series of related transactions, whether directly or indirectly, and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, unless approved in writing by the holders of two thirds of the voting power of the outstanding Series A Preferred Shares and Series B Preferred Shares (voting as a single class on an as-converted basis) in advance:
(i) any amendment or change of the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series A Preferred Shares or the Series B Preferred Shares;
(ii) any action that authorizes, creates or issues (A) any class or series of Equity Securities of any Group Company having rights, preferences, privileges or powers superior to or on a parity with the Series A Preferred Shares or the Series B Preferred Shares, whether as to liquidation, conversion, dividend, voting, redemption, or otherwise, or (B) any other Equity Securities of any Group Company except for the Conversion Shares;
(iii) any action that reclassifies any outstanding shares into shares having rights, preferences, privileges or powers senior to or on a parity with the Series A Preferred Shares or the Series B Preferred Shares, whether as to liquidation, conversion, dividend, voting, redemption, or otherwise.
10.2 Acts of the Group Companies Requiring Approval of Series C Preferred Holders. Regardless of anything else contained herein or in the Charter Documents of any Group Company, no Group Company shall take, permit to occur, approve, authorize, or agree or commit to do any of the following, and no Party shall permit any Group Company to, and the shareholders of the Company shall not permit the Company to take, permit to occur, approve, authorize, or agree or commit to do any of the following, whether in a single transaction or a series of related transactions, whether directly or indirectly, and whether or not by amendment, merger, consolidation, scheme of arrangement arrangement, amalgamation, or otherwise, unless approved in writing by the holders of a majority of the voting power of the outstanding of Series C Preferred Shares:
(i) take any amendment or change of the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series C Preferred Shares;
(ii) any action that authorizes, creates or issues (A) any class or series of Equity Securities of any Group Company having rights, preferences, privileges or powers superior to or on a parity with the Series C Preferred Shares, whether as to liquidation, conversion, dividend, voting, redemption, or otherwise, or (B) any other Equity Securities of any Group Company except for the Conversion Shares;
(iii) any action that reclassifies any outstanding shares into shares having rights, preferences, privileges or powers senior to or on a parity with the Series C Preferred Shares, whether as to liquidation, conversion, dividend, voting, redemption, or otherwise.
10.3 Acts of the Group Companies Requiring Approval of Preferred Holders. Regardless of anything else contained herein or in the Charter Documents of any Group Company, no Group Company shall take, permit to occur, approve, authorize, or agree or commit to do any of the following actions following, and no Party shall permit any Group Company to, and the shareholders of the Company shall not permit the Company to take, permit to occur, approve, authorize, or agree or commit to do any of the following, whether in a single transaction or a series of related transactions, whether directly or indirectly, and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, unless approved in writing by the holders of two thirds of the voting power of the outstanding Preferred Shares (voting as a single class on an as-converted basis) in advance, including the approval of a majority of the voting power of the outstanding of Series C Preferred Shares:
(i) any purchase, repurchase, redemption or retirements of any of the voting Equity Securities of any Group Company other than those pursuant to contractual rights to repurchase shares held by employees, directors or consultants of the Company or its Subsidiaries upon termination of their employment or services in connection accordance with the ESOP or the Restricted Share Agreements, or pursuant to the exercise of a Non-Liquidation M&Acontractual right of first refusal held by such Group Company, if any;
(ii) without any amendment or modification to or waiver under any of the prior vote Charter Documents of any Group Company, other than amendments pursuant to and in compliance with Section 12.17 hereof;
(iii) any declaration, set aside or written payment of a dividend or other distribution by any Group Company except for any distribution or dividend with respect to which the sole recipient of any proceeds therefrom is the Company;
(iv) any transaction (including but not limited to the termination, extension, continuation after expiry, renewal, amendment, variation or waiver of any term under agreement with respect to any transaction or series of transactions) with any Related Party;
(v) any sale, transfer, or other disposal of, or the incurrence of any Lien on, any substantial part of the assets of any Group Company;
(vi) the commencement of or consent to any proceeding seeking (i) to adjudicate it as bankrupt or insolvent, (ii) liquidation, winding up, dissolution, reorganization, or arrangement of any of the Group Companies under any Law relating to bankruptcy, insolvency or reorganization or relief of debtors, which is not resulted from or a part of the Trade Sale, or (iii) the entry of an order for relief or the appointment of a receiver, trustee, or other similar official for it or for any substantial part of its property;
(vii) any change of the size or composition of the board of directors of any Group Company other than changes pursuant to and in compliance with Section 9 hereof; or
(viii) any investment in, or divestiture or sale by any Group Company of an interest in a Subsidiary.
10.4 Acts of the Company Requiring Supermajority Approval of the Shareholders. Regardless of anything else contained herein or in the Charter Documents of any Group Company, no Group Company shall take, permit to occur, approve, authorize, or agree or commit to any Trade Sale, and no Party shall permit any Group Company to and the Shareholders of the Company shall not permit the Company to take, permit to occur, approve, authorize, or agree or commit to any Trade Sale, whether in a single transaction or a series of related transactions, whether directly or indirectly, and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, unless approved in writing by the holders of at least 5067% of the then voting power of all outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately as a single class.
(a) to liquidate, dissolve or wind up the affairs of the Company, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum and Articles;
(c) to create or authorize the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, or increase the authorized number of shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant voting together as ESOP pursuant to this Agreementa single class and calculated on an as-converted basis);
, which consent must include the written consent of holders of a majority of outstanding Preferred Shares (e) to purchase or redeem or pay any dividend voting together as one class and on any capital stock prior to an as-converted basis), the written consent of holders of a majority of outstanding Series A Preference C Preferred Shares, and the Series B Preference Shares or the Series D Preference written consent of holders of a majority of outstanding Ordinary Shares (other than stock repurchased from former employees excluding the Ordinary Shares which the Preferred Shares are converted or consultants in connection with convertible into). After the cessation receipt of their employment/servicessuch consents and approvals, at the lower each Shareholder of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien onshall consent to such Trade Sale and do and perform, make a call on or forfeit any Shares held by BlueFocus representing cause to be done and performed, acts and things reasonably necessary to facilitate the unpaid Residual Amount (Trade Sale if any) such Trade Sale has been duly approved in accordance with this Section 10.4.
10.5 Acts of the Memorandum and Articles after July 1, 2015;
(f) to create Group Companies Requiring Preferred Directors Approval. Regardless of anything else contained herein or authorize in the creation Charter Documents of any debt security (other than equipment leases Group Company, no Group Company shall take, permit to occur, approve, authorize, or bank lines of credit) unless such debt security has received the prior approval agree or commit to do any of the Boardfollowing, including and no Party shall permit any Group Company to, and the shareholders of the Company shall not permit the Company to, take, permit to occur, approve, authorize, or agree or commit to do any of the following, whether in a single transaction or a series of related transactions, whether directly or indirectly, and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, unless approved by a majority of the board of directors of such Group Company (which majority must include the approval of the at least one Series A Director, the Series B Director and the Series D TBP Director, or their respective equivalents at the board of such Group Company):
(i) incurrence by the Group Companies of Indebtedness or guarantees of Indebtedness in excess of RMB500,000 individually or in the aggregate during any fiscal year;
(gii) to increase the purchase or decrease lease by the size Group Companies of the Boardany business and/or assets valued in excess of RMB1,000,000 individually during any fiscal year;
(hiii) to approve the investment by any change Group Company in any other Person in excess of RMB500,000 individually or in the business scope aggregate during any fiscal year;
(iv) the approval of, or activities any deviation from or amendment of, the annual budget of the any Group Company;
(iv) to take actions subject to the Section 11.6 below, the adoption, amendment or termination of the ESOP or any other protective provisions equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies;
(vi) any loans to be employees;
(vii) the appointment or removal of the Auditors or the auditors for any other Group Company, or the change of the term of the fiscal year for any Group Company;
(viii) any public offering of any Equity Securities of any Group Company, other than a Qualified IPO;
(ix) any material change to the business scope, or nature of business of any Group Company, or cessation of any business line of any Group Company;
(x) any adoption of or change to, a significant tax or accounting practice or policy or any internal financial controls and authorization policies, or the making of any significant tax or accounting election; or
(xi) any other material actions or transaction which is not within the ordinary course of business of such Group Company consistent with its past practice, and which is beyond the business scope of applicable Group Company as set forth in the definitive agreements in connection with Recitals and the Series A financingnatural development, the Series B financing extension or the Series D financing;
(j) to approve and change any compensation package derivative of the management of businesses under the Company, including but not limited to the chief executive officer, general manager, and any other key employee; and
(k) to agree or undertake to do any of the foregoingaforesaid business scope.
Appears in 1 contract
Sources: Shareholder Agreements
Protective Provisions. 10.1 Approval of Series A Preference Shares, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in In addition to any such other vote or consent required elsewhere limitations as may be provided in the Memorandum and Articles or by applicable Lawand the Companies Law (2009 Revision) of the Cayman Islands, the Company shall not, and Members shall cause the other Group Companies to not, and the holders of Ordinary Shares shall exercise all of their rights with respect to such Ordinary Shares so as to cause the Company shall procure that the Company and each of its Subsidiaries shall not (directly Group Companies to not, effect or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take otherwise consummate any of the following actions (other than those in connection with a Non-Liquidation M&A) acts without first obtaining,
7.1 the prior vote or written consent approval of (i) the holder(s) of at least 75% of the holders outstanding Series A Shares and Series A1 Shares (in aggregate and on an as-converted basis), and (ii) the holder(s) of at least 50% of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately B1 Shares (in aggregate and on an as converted basis); provided that such requirement shall terminate upon a single class.Qualified Public Offering:
(a) to liquidate, dissolve any amendment or wind up the affairs change of the Companyrights, preferences, privileges or powers of, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum and Articles;
(c) to create or authorize restrictions provided for the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Sharesbenefit of, the Series B Preference Preferred Shares or the Series D Preference Shares, or increase the authorized number of shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(b) any action to authorize, create or issue shares of any class or series of the Company having preferences superior to or on a parity with the Preferred Shares in any aspects including without limitation, dividend rights, redemption rights and/or liquidation rights;
(c) any new issuance of any equity securities of the Company, including any change in the total number of authorized Series B Shares and Series B1 Shares, but excluding (i) any issuance of the Series B1 Shares authorized under the Purchase Agreement, (ii) any issuance of Ordinary Shares upon conversion of the Preferred Shares, (iii) the issuance of 66,580,000 Ordinary Shares upon the exercise of the option held by Winsome Group Limited on behalf of Ma ▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ Ho, Ma Wen Lie, ▇▇▇▇ Lo Yin, Li Jin and other officers, employees and advisors of the Company, (iv) the issuance of up to take actions subject 151,430,000 Ordinary Shares (or options or warrants therefor) pursuant to other protective provisions employee equity incentive plans, and (v) the issuance of up to be set forth in 50,246,000 Ordinary Shares upon the definitive agreements in connection exercise of the options granted to certain individuals under the Company’s 2009 Share Incentive Plan;
(d) any action of the Company to reclassify any outstanding shares into shares having preferences or priority as to dividends or assets senior to or on a parity with the Series A financingpreference of the Preferred Shares;
(e) any increase or decrease of the authorized number of Ordinary Shares or Preferred Shares of the Company;
(f) any amendment of the Memorandum and Articles of Association or other charter documents of the Company (including any Major Subsidiary);
(g) any merger or consolidation of the Company (including any Subsidiary) with or into any other business entity in which the shareholders of the Company (including any Subsidiary) immediately after such merger or consolidation held shares representing less than a majority of the voting power of the outstanding share capital of the surviving business entity;
(h) any transaction or series of transactions that would result in a change of control of the Company (including any Subsidiary);
(i) the sale, lease, transfer or other disposition of all or substantially all of the Series B financing or assets of the Series D financingCompany (including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries;
(j) to approve and change any compensation package licensing or other transfer of the management patents, copyrights, trademarks or other intellectual property of the CompanyCompany (including any Subsidiary) other than in the ordinary course of its business, including but not limited to except for intra-group transactions among the chief executive officer, general manager, Company and any other key employee; andSubsidiaries;
(k) any increase or decrease of the authorized number of the members of the Board (including any committees of the Board) of the Company;
(l) effect a liquidation, dissolution or winding up of the Company (including any Subsidiary);
(m) the declaration or payment of a dividend or other distribution on Ordinary Shares or Preferred Shares of the Company;
(n) any increase of the number of Ordinary Shares of the Company reserved under any employee equity incentive plan;
(o) any increase in compensation of any employee of the Company (including any Subsidiary) with an annual salary of US$50,000 or more by more than 20% in a twelve (12) month period;
(p) the extension by the Company of any loan or guarantee for indebtedness to agree any director, officer, employee or undertake affiliate of the Company (including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries;
(q) any incurrence of indebtedness in excess of US$1,000,000 in the aggregate to do the Company (including any Subsidiary), or creation of any encumbrance whatsoever upon the assets, patents, copyrights, trademarks or other intellectual property of the Company (including any Subsidiary);
(r) any purchase by the Company (including any Subsidiary) of real property with a value of US$1,000,000 or more, or any purchase of production facilities with a value of US$500,000 or more, individually or in the aggregate;
(s) any transaction or series of transactions that are not in the ordinary course of the Company’s business where the value involved exceeds US$1,000,000, individually or in the aggregate, during any twelve (12) month period,;
(t) approval of the annual consolidated budget of the Company;
(u) the appointment and removal of any key officer of the Company (including any Major Subsidiary), including the Chief Executive Officer and the Chief Financial Officer;
(v) the appointment and/or reappointment of auditors of the Company; or
(w) any transaction involving both the Company (including any Subsidiary) and a shareholder of any Group Company or any of the foregoingCompany’s employees, officers, directors or shareholders or any affiliate of a shareholder of any Group Company or any of such affiliate’s officers, directors or shareholders, except for intra-group transactions among the Company and any Subsidiaries and employment contracts between a Group Company and its employees that are not otherwise subject to this Section 7, and
7.2 the prior written approval of the holder(s) as at the date hereof (taking no account of any share issuances after the date hereof) of at least 96% of the aggregate of Ordinary Shares and Preferred Shares (on an as-converted basis), provided that such requirement shall terminate upon a Qualified IPO, any repurchase or redemption of any equity securities of the Company other than (A) pursuant to contractual rights to repurchase Ordinary Shares from the employees, directors or consultants of the Company upon termination of their employment or services or (B) pursuant to a contractual right of first refusal held by the Company. Provided, however that, to the extent that the applicable laws prevent the Company from being bound by any of the above provisions, such provisions shall be binding as amongst the parties hereto (other than the Company) and such parties shall take all actions necessary to give effect to such provisions.
Appears in 1 contract
Protective Provisions. 10.1 Approval of Series A Preference SharesThe Partnership and the General Partner hereby covenant and agree that, Series B Preference Shares, Series D Preference Shares. For so for as long as Bertelsmannany Preferred Units are outstanding, Sumitomo and BlueFocus respectively holds no less than 448,801 Sharesneither the Partnership nor the General Partner shall, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events)Partnership and the General Partner shall cause their respective Subsidiaries not to, in addition to any other vote undertake or consent required elsewhere in the Memorandum and Articles or by applicable Law, the Company shall not, and Members of the Company shall procure that the Company and each of its Subsidiaries shall not (directly or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take permit any of the following actions (other than those in connection with a Non-Liquidation M&A) actions, directly or indirectly, without the prior vote or written consent of the holders of at least 50% of the then outstanding Series D Preference Shares, the holders record of at least 50% a majority of the Preferred Units then outstanding Series B Preference Shares and outstanding:
(1) in the holders of at least 50% case of the then outstanding Series A Preference SharesPartnership, each voting separately as a single class.
(a) to liquidate, dissolve authorize or wind up the affairs of the Company, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum and Articles;
(c) to create or authorize the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Sharesissue, or increase the authorized number or issued amount of, (A) equity securities ranking, as to distributions and upon liquidation, on a parity with or senior to the Preferred Units or (B) Common Units or other equity securities ranking, as to distributions and upon liquidation, junior to the Preferred Units, to the extent that such Common Units or other junior equity securities contain any rights that restrict in any way management of the Partnership, the General Partner or their respective Subsidiaries or would reasonably be expected to interfere with the Preferred Units or the rights of the holders thereof; and (2) in the case of the General Partner, any Subsidiary of the General Partner or any Subsidiary of the Partnership, authorize or issue additional (A) shares of preferred stock or preferred equity securities or (B) shares of common stock or common equity securities or other equity securities ranking, as to distributions and upon liquidation, junior to shares of such entity’s preferred stock or preferred equity securities, to the extent that such shares of common stock, common equity securities or other junior equity securities contain any rights that restrict in any way management of the General Partner, the Partnership or their respective Subsidiaries or would reasonably be expected to interfere with the Preferred Units or the rights of the holders thereof;
(ii) amend, alter, repeal or waive any of the provisions of (1) this Amendment, the Purchase Agreement or any of the other Transaction Documents or the transactions contemplated hereby or thereby or (2) the certificate of limited partnership of the Partnership, the Partnership Agreement, the Articles of Incorporation or bylaws of the General Partner or the organizational documents of any of their respective Subsidiaries, in the case of clause (2) only, to the extent that such amendment would reasonably be expected to adversely affect the Preferred Units or, in the event that any Preferred Units have been exchanged for Series A Preferred Shares pursuant to Section 10, the Series A Preference SharesPreferred Shares or the respective rights of the holders thereof;
(iii) incur, renew, refinance, modify or otherwise discharge any Indebtedness of the Partnership, the General Partner or any of their respective Subsidiaries, or extend credit, make a loan or become a guarantor or surety for debt of another party, to the extent that any such action would cause a breach, violation of or failure to meet one or more of the Financial Covenants;
(iv) redeem, purchase or otherwise acquire for any consideration (1) in the case of the Partnership, equity securities of the Partnership that rank, as to distributions and upon liquidation, junior to the Preferred Units, including Common Units, and (2) in the case of the General Partner, any Subsidiary of the General Partner or any Subsidiary of the Partnership, any class or series of capital stock or equity securities; provided, that the foregoing shall not prohibit the following: (A) redemptions pursuant to the Share Redemption Program so long as a Cash Flow Sweep Event is not in effect; (B) redemptions of Common Units in exchange for which the General Partner issues REIT Shares to the holders of such Common Units as the sole consideration therefor pursuant to the terms of the Partnership Agreement; and (C) redemptions of Common Units for cash pursuant to the terms of the Contribution Agreements in an aggregate amount not to exceed $5.0 million;
(v) hold assets or engage in any business outside the Partnership, the General Partner or their respective Subsidiaries;
(vi) engage in any transaction with an Affiliate of the Partnership, the General Partner or their respective Subsidiaries or amend an agreement with any such Affiliate to the extent that such transaction or amendment would reasonably be expected to adversely affect the Preferred Units or, in the event that any Preferred Units have been exchanged for Series A Preferred Shares pursuant to Section 10, the Series B Preference A Preferred Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding rights of the respective holders thereof; provided, that the foregoing shall not prohibit the following: (1) transactions described in the Advisory Agreement or in one or more of the Series A Preference Shares, Property Management Agreements with the Series B Preference Shares or Property Manager; (2) the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares annual approval of the Company Advisory Agreement by the independent members of the Board of Directors of the General Partner, as required by the Advisory Agreement; and (other than grant stock options 3) transactions contemplated as of the Date of Issuance to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to be entered into by the Series A Preference Shares, Partnership and the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants General Partner in connection with the cessation DST Program or other Affiliated contributions or exchanges;
(vii) engage in a Change of Control;
(viii) commence or suffer to exist an Event of Bankruptcy as to the Partnership, the General Partner or any of their employment/servicesrespective Subsidiaries;
(ix) pay any special distributions (which, at for purposes hereof, shall mean any distribution other than a distribution made on a regular monthly basis consistent with past practice) on (1) in the lower case of fair market value the Partnership, Common Units or cost)other equity securities that rank, provided thatas to distributions and upon liquidation, no vote junior to the Preferred Units and (2) in the case of the General Partner, any Subsidiary of the General Partner or written any Subsidiary of the Partnership, shares of common stock or common equity securities or other equity securities that rank, as to distributions and upon liquidation, junior to such entity’s shares of preferred stock or preferred equity securities; provided, that the foregoing shall not prohibit special distributions that are (x) made pursuant to and in accordance with Section 7(a) or 7(b) or (y) necessary to preserve the General Partner’s status as a REIT under the Code; or
(x) engage in a recapitalization, reorganization, merger, unit or stock split, statutory unit or stock exchange, sale of all or substantially all of such entity’s assets, tender offer for all or substantially all of its Common Units, shares of common stock or other common equity securities, as the case may be, or other similar transaction. Neither the Partnership nor the General Partner shall take, and shall cause their respective Subsidiaries not to take, any action in furtherance of any of the foregoing actions without obtaining the required consent under therefor, as specified in this Section 7(d). Notwithstanding any provision in this Section 7(d) to the contrary, the Partnership shall be required from able to enter into tax protection agreements in the Holders ordinary course of its business. In the event that any Preferred Units have been exchanged for Series D A Preferred Shares before pursuant to Section 10, then the Company may enforce any paramount lien onGeneral Partner, make a call on as the holder of such exchanged Preferred Units, shall provide or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if anywithhold its consent pursuant to this Section 7(d) in accordance with the Memorandum determination of (and Articles after July 1, 2015;
(fin the same proportion as) the holders of such Series A Preferred Shares pursuant to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval terms of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package of the management of the Company, including but not limited to the chief executive officer, general manager, and any other key employee; and
(k) to agree or undertake to do any of the foregoingArticles Supplementary.
Appears in 1 contract
Sources: Limited Partnership Agreement (Griffin Capital Essential Asset REIT, Inc.)
Protective Provisions. 10.1 Approval of Series A Preference Shares, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in In addition to any such other vote or consent required elsewhere limitations as may be provided in the Memorandum and Articles or by applicable Lawand the BVI Business Companies ▇▇▇ ▇▇▇▇, the Company shall not, and Members shall cause the other Group Companies to not, and the holders of Ordinary Shares shall exercise all of their rights with respect to such Ordinary Shares so as to cause the Company shall procure that the Company and each of its Subsidiaries shall not (directly Group Companies to not, effect or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take otherwise consummate any of the following actions (other than those in connection with a Non-Liquidation M&A) acts without first obtaining.
7.1 the prior vote or written consent approval of (i) the holder(s) of at least 75% of the holders outstanding Series A Shares and Series A1 Shares (in aggregate and on an as-converted basis), and (ii) the holder(s) of at least 50% of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately B1 Shares (in aggregate and on an as converted basis); provided that such requirement shall terminate upon a single class.Qualified Public Offering:
(a) to liquidate, dissolve any amendment or wind up the affairs change of the Companyrights, preferences, privileges or powers of, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum and Articles;
(c) to create or authorize restrictions provided for the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Sharesbenefit of, the Series B Preference Preferred Shares or the Series D Preference Shares, or increase the authorized number of shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(b) any action to authorize, create or issue shares of any class or series of the Company having preferences superior to or on a parity with the Preferred Shares in any aspects including without limitation, dividend rights, redemption rights and/or liquidation rights;
(c) any new issuance of any equity securities of the Company, including any change in the total number of authorized Series B Shares and Series B1 Shares, but excluding (i) any issuance of the Series B1 Shares authorized under the Purchase Agreement, (ii) any issuance of Ordinary Shares upon conversion of the Preferred Shares, (iii) the issuance of 66,580 Ordinary Shares upon the exercise of the option currently held by Winsome Group Limited on behalf of Ma ▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ Ho, Ma Wen Lie, ▇▇▇▇ Lo Yin, Li Jin and other officers, employees and advisors of the Company, (iv) the issuance of up to take actions subject 151,430 Ordinary Shares (or options or warrants therefor) pursuant to other protective provisions employee equity incentive plans approved by the Compensation Committee, and (v) the issuance of up to be set forth in 50,246 Ordinary Shares upon the definitive agreements in connection exercise of the options granted to certain individuals pursuant to the resolutions of the Company’s directors passed on April 16, 2009;
(d) any action of the Company to reclassify any outstanding shares into shares having preferences or priority as to dividends or assets senior to or on a parity with the Series A financingpreference of the Preferred Shares;
(e) any increase or decrease of the authorized number of Ordinary Shares or Preferred Shares of the Company;
(f) any amendment of the Memorandum and Articles of Association or other charter documents of the Company (including any Major Subsidiary);
(g) any merger or consolidation of the Company (including any Subsidiary other than Linong Agriculture Technology Co., Ltd. (Tianjin)) with or into any other business entity in which the Series B financing shareholders of the Company (including any Subsidiary) immediately after such merger or consolidation held shares representing less than a majority of the Series D financingvoting power of the outstanding share capital of the surviving business entity;
(h) any transaction or series of transactions that would result in a change of control of the Company (including any Subsidiary other than Linong Agriculture Technology Co., Ltd. (Tianjin));
(i) the sale, lease, transfer or other disposition of all or substantially all of the assets of the Company (including any Subsidiary other than Linong Agriculture Technology Co., Ltd. (Tianjin)), except for intra-group transactions among the Company and any Subsidiaries;
(j) to approve and change any compensation package licensing or other transfer of the management patents, copyrights, trademarks or other intellectual property of the CompanyCompany (including any Subsidiary) other than in the ordinary course of its business, including but not limited to except for intra-group transactions among the chief executive officer, general manager, Company and any other key employee; andSubsidiaries;
(k) any increase or decrease of the authorized number of the members of the Board (including any committees of the Board) of the Company;
(l) effect a liquidation, dissolution or winding up of the Company (including any Subsidiary other than Linong Agriculture Technology Co., Ltd. (Tianjin));
(m) the declaration or payment of a dividend or other distribution on Ordinary Shares or Preferred Shares of the Company;
(n) any increase of the number of Ordinary Shares of the Company reserved under any employee equity incentive plan;
(o) any increase in compensation of any employee of the Company (including any Subsidiary) with an annual salary of US$50,000 or more by more than 20% in a twelve (12) month period;
(p) the extension by the Company of any loan or guarantee for indebtedness to agree any director, officer, employee or undertake affiliate of the Company (including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries;
(q) any incurrence of indebtedness in excess of US$1,000,000 in the aggregate to do the Company (including any Subsidiary), or creation of any encumbrance whatsoever upon the assets, patents, copyrights, trademarks or other intellectual property of the Company (including any Subsidiary);
(r) any purchase by the Company (including any Subsidiary) of real property with a value of US$1,000,000 or more, or any purchase of production facilities with a value of US$500,000 or more, individually or in the aggregate;
(s) any transaction or series of transactions that are not in the ordinary course of the Company’s business where the value involved exceeds US$1,000,000, individually or in the aggregate, during any twelve (12) month period, except for the disposition of any equity interest in, and/or any asset of, Linong Agriculture Technology Co., Ltd. (Tianjin));
(t) approval of the annual consolidated budget of the Company;
(u) the appointment and removal of any key officer of the Company (including any Major Subsidiary), including the Chief Executive Officer and the Chief Financial Officer;
(v) the appointment and/or reappointment of auditors of the Company; or
(w) any transaction involving both the Company (including any Subsidiary) and a shareholder of any Group Company or any of the foregoingCompany’s employees, officers, directors or shareholders or any affiliate of a shareholder of any Group Company or any of such affiliate’s officers, directors or shareholders, except for intra-group transactions among the Company and any Subsidiaries and employment contracts between a Group Company and its employees that are not otherwise subject to this Section 7, and
7.2 the prior written approval of the holder(s) as at the date hereof (taking no account of any share issuances after the date hereof) of at least 96% of the aggregate of Ordinary Shares and Preferred Shares (on an as-converted basis), provided that such requirement shall terminate upon a Qualified IPO, any repurchase or redemption of any equity securities of the Company other than (A) pursuant to contractual rights to repurchase Ordinary Shares from the employees, directors or consultants of the Company upon termination of their employment or services or (B) pursuant to a contractual right of first refusal held by the Company. Provided, however that, to the extent that the applicable laws prevent the Company from being bound by any of the above provisions, such provisions shall be binding as amongst the parties hereto (other than the Company) and such parties shall take all actions necessary to give effect to such provisions.
Appears in 1 contract
Sources: Share Subscription Agreement (Le Gaga Holdings LTD)
Protective Provisions. 10.1 Approval of Series A Preference Shares, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in In addition to any such other vote or consent required elsewhere limitations as may be provided in the Memorandum and Articles or by applicable Lawand the BVI Business Companies ▇▇▇ ▇▇▇▇, the Company shall not, and Members shall cause the other Group Companies to not, and the holders of Ordinary Shares shall exercise all of their rights with respect to such Ordinary Shares so as to cause the Company shall procure that the Company and each of its Subsidiaries shall not (directly Group Companies to not, effect or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take otherwise consummate any of the following actions (other than those in connection with a Non-Liquidation M&A) acts without first obtaining.
7.1 the prior vote or written consent approval of (i) the holders(s) of at least 75% of the holders outstanding Series A Shares and Series A1 Shares (in aggregate and on an as-converted basis), and (ii) the holder(s) of at least 50% of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately (on an as converted basis); provided that such requirement shall terminate upon a single class.Qualified Public Offering:
(a) to liquidate, dissolve any amendment or wind up the affairs change of the Companyrights, preferences, privileges or powers of, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum and Articles;
(c) to create or authorize restrictions provided for the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Sharesbenefit of, the Series B Preference Preferred Shares or the Series D Preference Shares, or increase the authorized number of shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(b) any action to authorize, create or issue shares of any class or series of the Company having preferences superior to or on a parity with the Preferred Shares in any aspects including without limitation, dividend rights, redemption rights and/or liquidation tights;
(c) any new issuance of any equity securities of the Company, including any change in the total number of authorized Series B Shares, but excluding (i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, any issuance of the Series B financing Shares authorized under the Purchase Agreement (ii) any issuance of Ordinary Shares upon conversion of the Preferred Shares, (iii) the issuance of 66,580 Ordinary Shares upon the exercise of the option currently held by Winsome Group Limited on behalf of Ma ▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ Ho, Ma Wen Lie, ▇▇▇▇ Lo Yin, Li Jin and other officers, employees and advisors of the Company, and (iv) the issuance of up to 151,430 Ordinary Shares (or options or warrants therefor) pursuant to employee equity incentive plans approved by the Series D financingCompensation Committee;
(d) any action of the Company to reclassify any outstanding shares into shares having preferences or priority as to dividends or assets senior to or on a parity with the preference of the Preferred Shares;
(e) any increase or decrease of the authorized number of Ordinary Shares or Preferred Shares of the Company;
(f) any amendment of the Memorandum and Articles of Association or other charter documents of the Company (including any Major Subsidiary);
(g) any merger or consolidation of the Company (including any Subsidiary) with or into any other business entity in which the shareholders of the Company (including any Subsidiary) immediately after such merger or consolidation held shares representing less than a majority of the voting power of the outstanding share capital of the surviving business entity;
(h) any transaction or series of transactions that would result in a change of control of the Company (including any Subsidiary);
(i) the sale, lease, transfer or other disposition of all or substantially all of the assets of the Company (including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries;
(j) to approve and change any compensation package licensing or other transfer of the management patents, copyrights, trademarks or other intellectual property of the CompanyCompany (including any Subsidiary) other than in the ordinary course of its business, including but not limited to except for intra-group transactions among the chief executive officer, general manager, Company and any other key employee; andSubsidiaries;
(k) any increase or decrease of the authorized number of the Board (including any committees of the Board) of the Company;
(l) effect a liquidation, dissolution or winding up of the Company (including any Subsidiary);
(m) the declaration or payment of a dividend or other distribution on Ordinary Shares or Preferred Shares of the Company;
(n) any increase of the number of Ordinary Shares of the Company reserved under any employee equity incentive plan;
(o) any increase in compensation of any employee of the Company (including any Subsidiary) with an annual salary of US$50,000 or more by more than 20% in a twelve (12) month period;
(p) the extension by the Company of any loan or guarantee for indebtedness to agree any director officer, employee or undertake affiliate of the Company (including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries;
(q) any incurrence of indebtedness in excess of US$1,000,000 in the aggregate to do the Company (including any Subsidiary), or creation of any encumbrance whatsoever upon the assets, patents, copyrights, trademarks or other intellectual property of the Company (including any Subsidiary);
(r) any purchase by the Company (including any Subsidiary) of real property with a value of US$1,000,000 or more, or any purchase of production facilities with a value of US$500,000 or more, individually or in the aggregate;
(s) any transaction or series of transactions that are not in the ordinary course of the Company’s business where the value involved exceeds US$1,000,000, individually or in the aggregate, during any twelve (12) month period;
(t) approval of the annual consolidated budget of the Company;
(u) the appointment and removal of any key officer of the Company (including any Major Subsidiary), including the Chief Executive Officer and the Chief Financial Officer;
(v) the appointment and/or reappointment of auditors of the Company; or
(w) any transaction involving both the Company (including any Subsidiary) and a shareholder of any Group Company or any of the foregoingCompany’s employees, officers, directors or shareholders or any affiliate of a shareholder of any Group Company or any of such affiliate’s officers, directors or shareholders, except for intra-group transactions among the Company and any Subsidiaries and employment contracts between a Group Company and its employees that are not otherwise subject to this Section 7, and
7.2 the prior written approval of the holder(s) as at the date hereof (taking no account of any share issuances after the date, hereof) of at least 96% of the aggregate of Ordinary Shares and Preferred Shares (on an as-converted basis), provided that such requirement shall terminate upon a Qualified IPO, any repurchase or redemption of any equity securities of the Company other than (A) pursuant to contractual rights to repurchase Ordinary Shares from the employees, directors or consultants of the Company upon termination of their employment or services or (B) pursuant to a contractual right of first refusal held by the Company. Provided, however that, to the extent that the applicable laws prevent the Company from being bound by any of the above provisions, such provisions shall be binding as amongst the parties hereto (other than the Company) and such parties shall take all actions necessary to give effect to such provisions.
Appears in 1 contract
Protective Provisions. 10.1 Approval of Series A Preference SharesThe Partnership and the General Partner hereby covenant and agree that, Series B Preference Shares, Series D Preference Shares. For so for as long as Bertelsmannany Preferred Units are outstanding, Sumitomo and BlueFocus respectively holds no less than 448,801 Sharesneither the Partnership nor the General Partner shall, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events)Partnership and the General Partner shall cause their respective Subsidiaries not to, in addition to any other vote undertake or consent required elsewhere in the Memorandum and Articles or by applicable Law, the Company shall not, and Members of the Company shall procure that the Company and each of its Subsidiaries shall not (directly or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take permit any of the following actions (other than those in connection with a Non-Liquidation M&A) actions, directly or indirectly, without the prior vote or written consent of the holders of at least 50% of the then outstanding Series D Preference Shares, the holders record of at least 50% a majority of the Preferred Units then outstanding Series B Preference Shares and outstanding:
(1) in the holders of at least 50% case of the then outstanding Series A Preference SharesPartnership, each voting separately as a single class.
(a) to liquidate, dissolve authorize or wind up the affairs of the Company, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum and Articles;
(c) to create or authorize the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Sharesissue, or increase the authorized number or issued amount of, (A) equity securities ranking, as to distributions and upon liquidation, on a parity with or senior to the Preferred Units or (B) Common Units or other equity securities ranking, as to distributions and upon liquidation, junior to the Preferred Units, to the extent that such Common Units or other junior equity securities contain any rights that restrict in any way management of the Partnership, the General Partner or their respective Subsidiaries or would reasonably be expected to interfere with the Preferred Units or the rights of the holders thereof; and (2) in the case of the General Partner, any Subsidiary of the General Partner or any Subsidiary of the Partnership, authorize or issue additional (A) shares of preferred stock or preferred equity securities or (B) shares of common stock or common equity securities or other equity securities ranking, as to distributions and upon liquidation, junior to shares of such entity’s preferred stock or preferred equity securities, to the extent that such shares of common stock, common equity securities or other junior equity securities contain any rights that restrict in any way management of the General Partner, the Partnership or their respective Subsidiaries or would reasonably be expected to interfere with the Preferred Units or the rights of the holders thereof;
(ii) amend, alter, repeal or waive any of the provisions of (1) this Designation of Rights, the Purchase Agreement or any of the other Transaction Documents or the transactions contemplated hereby or thereby or (2) the certificate of limited partnership of the Partnership, the Partnership Agreement, the Articles of Incorporation or bylaws of the General Partner or the organizational documents of any of their respective Subsidiaries, in the case of clause (2) only, to the extent that such amendment would reasonably be expected to adversely affect the Preferred Units or, in the event that any Preferred Units have been exchanged for Series A Preferred Shares pursuant to Section 10, the Series A Preference SharesPreferred Shares or the respective rights of the holders thereof;
(iii) incur, renew, refinance, modify or otherwise discharge any Indebtedness of the Partnership, the General Partner or any of their respective Subsidiaries, or extend credit, make a loan or become a guarantor or surety for debt of another party, to the extent that any such action would cause a breach, violation of or failure to meet one or more of the Financial Covenants;
(iv) redeem, purchase or otherwise acquire for any consideration (1) in the case of the Partnership, equity securities of the Partnership that rank, as to distributions and upon liquidation, junior to the Preferred Units, including Common Units, and (2) in the case of the General Partner, any Subsidiary of the General Partner or any Subsidiary of the Partnership, any class or series of capital stock or equity securities; provided, that the foregoing shall not prohibit the following: (A) redemptions pursuant to the Share Redemption Program so long as a Cash Flow Sweep Event is not in effect; (B) redemptions of Common Units in exchange for which the General Partner issues REIT Shares to the holders of such Common Units as the sole consideration therefor pursuant to the terms of the Partnership Agreement; and (C) redemptions of Common Units for cash pursuant to the terms of the Contribution Agreements in an aggregate amount not to exceed $5.0 million;
(v) hold assets or engage in any business outside the Partnership, the General Partner or their respective Subsidiaries;
(vi) engage in any transaction with an Affiliate of the Partnership, the General Partner or their respective Subsidiaries or amend an agreement with any such Affiliate to the extent that such transaction or amendment would reasonably be expected to adversely affect the Preferred Units or, in the event that any Preferred Units have been exchanged for Series A Preferred Shares pursuant to Section 10, the Series B Preference A Preferred Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding rights of the respective holders thereof; provided, that the foregoing shall not prohibit the following: (1) transactions described in the Advisory Agreement or in one or more of the Series A Preference Shares, Property Management Agreements with the Series B Preference Shares or Property Manager; (2) the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares annual approval of the Company Advisory Agreement by the independent members of the Board of Directors of the General Partner, as required by the Advisory Agreement; and (other than grant stock options 3) transactions contemplated as of the Date of Issuance to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to be entered into by the Series A Preference Shares, Partnership and the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants General Partner in connection with the cessation DST Program or other Affiliated contributions or exchanges;
(vii) engage in a Change of Control;
(viii) commence or suffer to exist an Event of Bankruptcy as to the Partnership, the General Partner or any of their employment/servicesrespective Subsidiaries;
(ix) pay any special distributions (which, at for purposes hereof, shall mean any distribution other than a distribution made on a regular monthly basis consistent with past practice) on (1) in the lower case of fair market value the Partnership, Common Units or cost)other equity securities that rank, provided thatas to distributions and upon liquidation, no vote junior to the Preferred Units and (2) in the case of the General Partner, any Subsidiary of the General Partner or written any Subsidiary of the Partnership, shares of common stock or common equity securities or other equity securities that rank, as to distributions and upon liquidation, junior to such entity’s shares of preferred stock or preferred equity securities; provided, that the foregoing shall not prohibit special distributions that are (x) made pursuant to and in accordance with Section 7(a) or 7(b) or (y) necessary to preserve the General Partner’s status as a REIT under the Code; or
(x) engage in a recapitalization, reorganization, merger, unit or stock split, statutory unit or stock exchange, sale of all or substantially all of such entity’s assets, tender offer for all or substantially all of its Common Units, shares of common stock or other common equity securities, as the case may be, Extraordinary Transaction (as defined in the Partnership Agreement) or other similar transaction. Neither the Partnership nor the General Partner shall take, and shall cause their respective Subsidiaries not to take, any action in furtherance of any of the foregoing actions without obtaining the required consent under therefor, as specified in this Section 7(d). Notwithstanding any provision in this Section 7(d) to the contrary, the Partnership shall be required from able to enter into tax protection agreements in the Holders ordinary course of its business. In the event that any Preferred Units have been exchanged for Series D A Preferred Shares before pursuant to Section 10, then the Company may enforce any paramount lien onGeneral Partner, make a call on as the holder of such exchanged Preferred Units, shall provide or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if anywithhold its consent pursuant to this Section 7(d) in accordance with the Memorandum determination of (and Articles after July 1, 2015;
(fin the same proportion as) the holders of such Series A Preferred Shares pursuant to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval terms of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package of the management of the Company, including but not limited to the chief executive officer, general manager, and any other key employee; and
(k) to agree or undertake to do any of the foregoingArticles Supplementary.
Appears in 1 contract
Sources: Limited Partnership Agreement (Griffin Capital Essential Asset REIT, Inc.)
Protective Provisions. 10.1 Approval of Series A Preference Shares8.1. In addition to such other limitations as may be provided in the Restated Articles, Series B Preference Shares, Series D Preference Shares. For for so long as Bertelsmannany Preferred Shares are outstanding, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in addition to any other vote or consent required elsewhere in the Memorandum and Articles or by applicable Law, the each Group Company shall not, and Members of the Company Founders and the BVI Companies shall procure that the each Group Company and each of its Subsidiaries shall not (directly or by amendmentnot, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take any of the following actions (other than those in connection with a Non-Liquidation M&A) without the prior affirmative vote or prior written consent of (i) the holders of at least shares carrying more than fifty percent (50% %) of the voting power of the then outstanding Series D Preference Preferred Shares, (ii) the holders of at least shares carrying more than fifty percent (50% %) of the voting power of the then outstanding Series B Preference C+ Preferred Shares and Series C-4 Preferred Shares, (iii) the holders of at least shares carrying more than fifty percent (50% %) of the voting power of the then outstanding Series C Preferred Shares, (iv) the holders of more than fifty percent (50%) of the then outstanding Series B-2 Preferred Shares, and (v) holders of shares carrying more than fifty percent (50%) of the voting power of the then outstanding Series A Preference Shares, each Preferred Shares and Series B-1 Preferred Shares (voting separately as a single class.separate classes):
(a) to liquidate, dissolve any amendment or wind up the affairs change of the Companyrights, preferences, privileges or powers of, or effect the restrictions provided for the benefit of any Liquidating Transactionof, the Preferred Shares;
(b) to amendany action that authorizes, alter, creates or repeal issues any provision class of shares of the Memorandum and Articlescapital of the Company having preferences superior to or on a parity with any of the Preferred Shares or any new issuance of any securities of the Company;
(c) any action that reclassifies any outstanding shares into shares having preferences or priority as to create dividends or authorize assets superior to or on a parity with the creation preference of any of the Preferred Shares;
(d) any repurchase or redemption of the equity securities of any Group Company other than pursuant to (i) the contractual rights to repurchase the Ordinary Shares or Preferred Shares from the employees, directors or consultants of any Group Company upon termination of their employment or services pursuant to the stock incentive plan or other equity incentive programs, or (ii) the redemption rights provided under the Company’s Memorandum and Articles of Association or other charter documents of any Group Company;
(e) any increase, decrease or cancellation of the authorized or issued share capital of any Group Company or any issuance, allotment, or sale of any shares or securities convertible into or carrying a right of subscription in respect of shares or any share warrants or grant or issue any other security convertible into options rights or exercisable for any equity security, having rights, preferences warrants or privileges senior to or on parity with which may require the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, or increase the authorized number issue of shares of in the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares future or do any act which has the effect of diluting or reducing the effective shareholding of the Investors in the Company;
(f) any amendment, modification or change of the Company’s Memorandum and Articles of Association or other charter documents of any Group Company;
(g) any dividend or distribution of the profits of the Company by way of dividend (interim or final), capitalization of reserves or otherwise, or any declaration therefor;
(h) any increase or decrease of the authorized size of the board of directors of any Group Company, or amend the rules of appointing the directors as provided herein, or amend the power of any Director;
(i) any sale of all or substantially of any of the Group Company’s assets, goodwill, or any material asset or undertaking of any Group Company;
(j) commencement of any liquidation, dissolution, winding up or termination of any Group Company;
(k) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any transaction in which the control of any Group Company is transferred, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company;
(l) the initial public offering of any of the Shares or other equity or debt securities of any Group Company (or as the case may be, the shares or securities of the relevant entity resulting from any merger, reorganization or other arrangements made by or to the Company for the purposes of public offering);
(m) any other event which may negatively affect the rights, preferences, privileges or powers of the Investors herein; provided that, where a special resolution or an ordinary resolution, as the case may be, is required by applicable statute to approve any of the matters listed above, and such matter has not received consent of the holders of shares carrying more than fifty percent (50%) of the voting power of the then outstanding Series A Preference D Preferred Shares, the holders of shares carrying more than fifty percent (50%) of the voting power of the then outstanding Series B Preference C+ Preferred Shares or the and Series D Preference C-4 Preferred Shares, provided thatthe holders of shares carrying more than fifty percent (50%) of the voting power of the then outstanding Series C Preferred Shares, no vote or written consent under this Section shall be required from and the Holders holders of more than fifty percent (50%) of the then outstanding Series D B-2 Preferred Shares, and holders of shares carrying more than fifty percent (50%) of the voting power of the then outstanding Series B-1 Preferred Shares before and Series A Preferred Shares (voting as separate classes), then the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with holders who voted against the special resolution or the ordinary resolution, as the case may be, shall together carry the number of votes equal to the votes of all members who voted for the resolution plus one.
8.2. In addition to such other limitations as may be provided in the Memorandum Restated Articles, for so long as any Preferred Shares are outstanding, each Group Company shall not, and Articles after July 1the Founders and the BVI Companies shall procure that each Group Company shall not, 2015take any of the following actions without the prior written approval of the Board (including the approval of all Investor Directors):
(a) ceasing to conduct or carrying on the business of any Group Company substantially as now conducted, any Group Company entering into any new business lines or changing any part of its business activities;
(b) deciding on the terms and conditions of the appointment of, and the compensation and salaries payable to, the Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and President of any Group Company, and any variations to any of such terms, conditions, compensation or salaries (provided that determination of such terms, conditions, compensation or salaries shall also be subject to the board approval);
(c) any approval of or amendment to or implementation of any stock incentive plan (including the ESOP, as defined in Section 9.6) or increase the number of shares reserved for any equity incentive plan (including the ESOP);
(d) to create, or issue any increase in aggregate compensation (including all benefits and bonus) of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to five most highly compensated employees or consultant as ESOP pursuant to this Agreement)officers of any Group Company by more than fifty percent (50%) in a twelve (12) months period;
(e) any disposing of or licensing to purchase any third party any patent, brand, copyright, trademark or redeem or pay any dividend intellectual property of the Group Company, unless such transaction occurs in the ordinary course of business of the Group Company and on any capital stock normal commercial terms and has been fully disclosed in writing to the Preferred Shareholders prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation entering into of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015such transaction;
(f) borrowing any money or obtaining any financial facilities except pursuant to create trade facilities obtained from banks or authorize other financial institutions in the creation ordinary course of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Directorbusiness;
(g) making any loan or advance or giving any credit to increase or decrease any Person outside the size ordinary course of the Boardbusiness;
(h) to approve any change investment in securities (excluding fixed-income securities) in a single transaction or a series of transactions where such investment would in the business scope aggregate exceed US$1,000,000, or activities of the Companyany investment in futures or derivatives;
(i) to take actions subject any incurrence of pledge, lien or charge (whether by way of fixed or floating change, mortgage encumbrance or other security) on all or any of the undertaking, assets or rights of any Group Company except those provided to other protective provisions to be set forth Group Companies or for the purpose of securing borrowings from banks or other financial institutions in the definitive agreements ordinary course of business in connection with the Series A financing, the Series B financing or the Series D financingan aggregate amount not to exceed US$1,000,000;
(j) any incurrence of material transaction outside the ordinary course of business of any Group Company in excess of US$1,000,000 or of any capital expenditure greater than US$1,000,000;
(k) any action to approve or make adjustments or modifications to terms of transactions between any directors, officers, or shareholders of any Group Company and change any compensation package of the management of the Group Company, including but not limited to the chief executive officermaking of any loans or advances, general managerwhether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness of liabilities of any director or shareholder of any Group Company;
(l) the adoption of and significant modifications to the annual budget or business plan of any Group Company;
(m) any appointment, replacement or removal of the auditor or any alteration of the fiscal or auditing policy of any Group Company, or change the financial year of the Company;
(n) acquiring or disposing of any investment into any entity (regardless if such investment may be capitalized on the Company’s balance sheet or not), in a single transaction or a series of transactions where such investment would in the aggregate exceed US$1,000,000, or incur any commitment in excess of US$1,000,000 at any time in respect of any one transaction or in excess of US$2,000,000 at any time in related transactions in any financial year of the Company and/or any subsidiary;
(o) any acquisition or formation of any subsidiary or acquisition of the whole or any substantial part of the undertakings, assets or business of any other key employee; andcompany or any entity or any entry into any joint venture or partnership with any other entity or any entry into any merger, consolidation or restructure, in excess of a consideration of more than US$2,000,000;
(kp) any action to agree enter into any related party transaction or undertake to do hiring any relative of any Founder by any Group Company; or
(q) any amendment, extension or termination of the foregoingControl Documents (as defined in the Series D-2 Share Purchase Agreement).
Appears in 1 contract
Sources: Shareholder Agreements (TuanChe LTD)
Protective Provisions. 10.1 Approval of Series A Preference Shares, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in In addition to any such other vote or consent required elsewhere limitations as may be provided in the Memorandum and Articles or by applicable Lawand the BVI Business Companies ▇▇▇ ▇▇▇▇, the Company shall not, and Members shall cause the other Group Companies to not, and the holders of Ordinary Shares shall exercise all of their rights with respect to such Ordinary Shares so as to cause the Company shall procure that the Company and each of its Subsidiaries shall not (directly Group Companies to not, effect or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take otherwise consummate any of the following actions acts without first obtaining,
(other than those in connection with a Non-Liquidation M&A1) without the prior vote or written consent approval of (i) the holder(s) of at least 75% of the holders outstanding Series A Shares and Series A1 Shares (in aggregate and on an as-converted basis), and (ii) the holder(s) of at least 50% of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% (on an as converted basis); provided that such requirement shall terminate upon a Qualified Public Offering:
i. any amendment or change of the then outstanding Series A Preference Sharesrights, each voting separately as a single class.
(a) to liquidatepreferences, dissolve privileges or wind up the affairs of the Companypowers of, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum and Articles;
(c) to create or authorize restrictions provided for the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Sharesbenefit of, the Series B Preference Preferred Shares or the Series D Preference Shares, or increase the authorized number of shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) ii. any action to take actions subject authorize, create or issue shares of any class or series of the Company having preferences superior to other protective provisions to be set forth in the definitive agreements in connection or on a parity with the Series A financingPreferred Shares in any aspects including without limitation, the Series B financing or the Series D financingdividend rights, redemption rights and/or liquidation rights;
(j) to approve and change iii. any compensation package new issuance of the management any equity securities of the Company, including any change in the total number of authorized Series B Shares, but not limited excluding (i) any issuance of the Series B Shares authorized under the Purchase Agreement, (ii) any issuance of Ordinary Shares upon conversion of the Preferred Shares, and (iii) the issuance of 66,580 Ordinary Shares reserved for issuance upon the exercise of the option currently held by Winsome Group Limited on behalf of Ma ▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ Ho, Ma Wen Lie, ▇▇▇▇ Lo Yin and other officers, employees and advisors of the Company, and (iv) the issuance of up to 151,430 Ordinary Shares (and/or options or warrants therefor) reserved for issuance pursuant to the chief executive employee equity incentive plans approved by the Compensation Committee (as defined in the Articles);
iv. any action of the Company to reclassify any outstanding shares into shares having preferences or priority as to dividends or assets senior to or on a parity with the preference of the Preferred Shares;
v. any increase or decrease of the authorized number of Ordinary Shares or Preferred Shares of the Company;
vi. any amendment of the Memorandum and Articles of Association or other charter documents of the Company (including any Major Subsidiary);
vii. any merger or consolidation of the Company (including any Subsidiary) with or into any other business entity in which the shareholders of the Company (including any Subsidiary) immediately after such merger or consolidation held shares representing less than a majority of the voting power of the outstanding share capital of the surviving business entity;
viii. any transaction or series of transactions that would result in a change of control of the Company (including any Subsidiary);
ix. the sale, lease, transfer or other disposition of all or substantially all of the assets of the Company (including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries;
x. any licensing or other transfer of the patents, copyrights, trademarks or other intellectual property of the Company (including any Subsidiary) other than in the ordinary course of its business, except for intra-group transactions among the Company and any Subsidiaries;
xi. any increase or decrease of the authorized number of the Board (including any committees of the Board) of the Company;
xii. effect a liquidation, dissolution or winding up of the Company (including any Subsidiary);
xiii. the declaration or payment of a dividend or other distribution on Ordinary Shares or Preferred Shares of the Company;
xiv. any increase of the number of Ordinary Shares of the Company reserved under any employee equity incentive plan;
xv. any increase in compensation of any employee of the Company (including any Subsidiary) with an annual salary of US$50,000 or more by more than 20% in a twelve (12) month period;
xvi. the extension by the Company of any loan or guarantee for indebtedness to any director, officer, general manageremployee or affiliate of the Company (including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries;
xvii. any incurrence of indebtedness in excess of US$1,000,000 in the aggregate to the Company (including any Subsidiary), or creation of any encumbrance whatsoever upon the assets, patents, copyrights, trademarks or other intellectual property of the Company (including any Subsidiary);
xviii. any purchase by the Company (including any Subsidiary) of real property with a value of US$1,000,000 or more, or any purchase of production facilities with a value of US$500,000 or more, individually or in the aggregate;
xix. any transaction or series of transactions that are not in the ordinary course of the Company’s business where the value involved exceeds US$1,000,000, individually or in the aggregate, during any twelve (12) month period;
xx. approval of the annual consolidated budget of the Company;
xxi. the appointment and removal of any key employeeofficer of the Company (including any Major Subsidiary), including the Chief Executive Officer and the Chief Financial Officer;
xxii. the appointment and/or reappointment of auditors of the Company; or
xxiii. any transaction involving both the Company (including any Subsidiary) and a shareholder of any Group Company or any of the Company’s employees, officers, directors or shareholders or any affiliate of a shareholder of any Group Company or any of such affiliate’s officers, directors or shareholders, except for intra-group transactions among the Company and any Subsidiaries and employment contracts between a Group Company and its employees that are not otherwise subject to this paragraph 7.3(h), and
(k2) the prior written approval of the holder(s) as at the date hereof (taking no account of any share issuances after the date hereof) of at least 96% of the aggregate of Ordinary Shares and Preferred Shares (on an as-converted basis), provided that such requirement shall terminate upon a Qualified IPO, any repurchase or redemption of any equity securities of the Company other than (A) pursuant to agree contractual rights to repurchase Ordinary Shares from the employees, directors or undertake consultants of the Company upon termination of their employment or services or (B) pursuant to do a contractual right of first refusal held by the Company. Provided, however that, to the extent that the applicable laws prevent the Company from being bound by any of the foregoingabove provisions, such provisions shall be binding as amongst the holders of Ordinary Shares and holders of Preferred Shares and such parties shall take all actions necessary to give effect to such provisions.
Appears in 1 contract
Sources: Share Subscription Agreement (Le Gaga Holdings LTD)
Protective Provisions. 10.1 Approval of Series A Preference SharesThe Partnership and the General Partner hereby covenant and agree that, Series B Preference Shares, for as long as any Series D Preference Shares. For so long as BertelsmannPreferred Units are outstanding, Sumitomo and BlueFocus respectively holds no less than 448,801 Sharesneither the Partnership nor the General Partner shall, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events)Partnership and the General Partner shall cause their respective Subsidiaries not to, in addition to any other vote undertake or consent required elsewhere in the Memorandum and Articles or by applicable Law, the Company shall not, and Members of the Company shall procure that the Company and each of its Subsidiaries shall not (directly or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take permit any of the following actions (other than those in connection with a Non-Liquidation M&A) actions, directly or indirectly, without the prior vote or written consent of the holders of at least 50% of the then outstanding Series D Preference Shares, the holders record of at least 50% a majority of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately as a single class.
(a) to liquidate, dissolve or wind up the affairs of the Company, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum and Articles;
(c) to create or authorize the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Shares, the Series B Preference Shares or the Series D Preference SharesPreferred Units then outstanding:
(1) in the case of the Partnership, authorize or issue, or increase the authorized number of shares of the Series A Preference Sharesor issued amount of, the Series B Preference Shares (A) equity securities ranking, as to distributions and upon liquidation, on a parity with or senior to the Series D Preference Shares Preferred Units or do (B) Common Units or other equity securities ranking, as to distributions and upon liquidation, junior to the Series D Preferred Units, to the extent that such Common Units or other junior equity securities contain any act which has rights that restrict in any way management of the effect of diluting Partnership, the General Partner or reducing their respective Subsidiaries or would reasonably be expected to interfere with the effective shareholding Series D Preferred Units or the rights of the holders thereof; and (2) in the case of the Series A Preference SharesGeneral Partner, any Subsidiary of the General Partner or any Subsidiary of the Partnership, authorize or issue additional (A) shares of preferred stock or preferred equity securities or (B) shares of common stock or common equity securities or other equity securities ranking, as to distributions and upon liquidation, junior to shares of such entity’s preferred stock or preferred equity securities, to the extent that such shares of common stock, common equity securities or other junior equity securities contain any rights that restrict in any way management of the General Partner, the Series B Preference Shares Partnership or their respective Subsidiaries or would reasonably be expected to interfere with the Series D Preference Shares, provided that, no vote Preferred Units or written consent under this Section shall be required from the Holders rights of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015holders thereof;
(dii) to createamend, alter, repeal or issue waive any of the provisions of (1) this Amendment or the Purchase Agreement or (2) the certificate of limited partnership of the Partnership, the Partnership Agreement, the Articles of Incorporation or bylaws of the General Partner or the organizational documents of any debenture of their respective Subsidiaries, in the case of clause (2) only, to the extent that such amendment would reasonably be expected to adversely affect the Series D Preferred Units or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares the rights of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement)holders thereof;
(eiii) to redeem, purchase or redeem or pay otherwise acquire for any dividend on any capital stock prior consideration (1) in the case of the Partnership, equity securities of the Partnership that rank, as to distributions and upon liquidation, junior to the Series A Preference SharesD Preferred Units, including Common Units, and (2) in the case of the General Partner, any Subsidiary of the General Partner or any Subsidiary of the Partnership, any class or series of capital stock or equity securities; provided, that the foregoing shall not prohibit the following: (A) redemptions pursuant to the Share Redemption Program; and (B) redemptions of Common Units in exchange for which the General Partner issues REIT Shares to the holders of such Common Units as the sole consideration therefor pursuant to the terms of the Partnership Agreement;
(iv) engage in a Change of Control;
(v) commence or suffer to exist an Event of Bankruptcy as to the Partnership, the Series B Preference Shares General Partner or any of their respective Subsidiaries;
(vi) pay any special distributions (which, for purposes hereof, shall mean any distribution other than a distribution made on a regular monthly basis consistent with past practice) on (1) in the case of the Partnership, Common Units or other equity securities that rank, as to distributions and upon liquidation, junior to the Series D Preference Shares Preferred Units and (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any2) in accordance with the Memorandum case of the General Partner, any Subsidiary of the General Partner or any Subsidiary of the Partnership, shares of common stock or common equity securities or other equity securities that rank, as to distributions and Articles after July 1upon liquidation, 2015;junior to such entity’s shares of preferred stock or preferred equity securities; provided, that the foregoing shall not prohibit special distributions that are necessary to preserve the General Partner’s status as a REIT under the Code; or
(fvii) to create engage in a recapitalization, reorganization, merger, unit or authorize stock split, statutory unit or stock exchange, sale of all or substantially all of such entity’s assets, tender offer for all or substantially all of its Common Units, shares of common stock or other common equity securities, as the creation of any debt security (case may be, or other than equipment leases or bank lines of credit) unless such debt security has received similar transaction. Neither the prior approval of Partnership nor the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package of the management of the Company, including but not limited to the chief executive officer, general managerGeneral Partner shall take, and shall cause their respective Subsidiaries not to take, any other key employee; and
(k) to agree or undertake to do action in furtherance of any of the foregoingforegoing actions without obtaining the required consent therefor, as specified in this Section 7(a). Notwithstanding any provision in this Section 7(a) to the contrary, the Partnership shall be able to enter into tax protection agreements in the ordinary course of its business.
Appears in 1 contract
Sources: Limited Partnership Agreement (Strategic Storage Trust VI, Inc.)
Protective Provisions. 10.1 Approval 7.1 Subject to the rights of Series A Preference Sharesseries of preferred stock which may from time to time come into existence, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in addition to any other vote or consent required elsewhere in the Memorandum and Articles or by applicable Lawshares of Series B1 Preferred Stock are outstanding, the Company Corporation shall not, and Members of without first obtaining the Company shall procure that the Company and each of its Subsidiaries shall not approval (directly at a meeting duly called or by amendmentwritten consent, merger, consolidation, amalgamation, scheme of arrangement or otherwiseas provided by law) take any of the following actions (other than those in connection with a Non-Liquidation M&A) without the prior vote or written consent of the holders of at least 50% of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately as a single class.Majority In Interest:
(a) Increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series B1 Preferred Stock (except to liquidatethe extent required to issue PIK Shares if required by the terms set forth herein, dissolve or wind up which for the affairs sake of clarity, and without otherwise limiting this provision, shall not require approval of the Company, or effect any Liquidating TransactionHolders);
(b) Re-issue any shares of Series B1 Preferred Stock converted or redeemed pursuant to amendthe terms of this Designation (except to the extent required to issue PIK Shares if required by the terms set forth herein, alterwhich for the sake of clarity, or repeal any provision and without otherwise limiting this provision, shall not require approval of the Memorandum and ArticlesHolders);
(c) to create Create, or authorize the creation of of, or issue or obligate itself to issue shares of, any other security convertible into class or exercisable for any equity security, having rights, preferences or privileges senior series of capital stock unless the same ranks junior to or on parity with (and not pari passu with) the Series A Preference SharesB1 Preferred Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the Series B Preference Shares or the Series D Preference Sharespayment of dividends and rights of redemption, or increase the authorized number of shares of any additional class or series of capital stock unless the same ranks junior to (and not pari passu with) the Series A Preference SharesB1 Preferred Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the Series B Preference Shares payment of dividends and rights of redemption, in each such case, other than issuances of (or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders in connection with issuances of) shares of Series D Shares before B1 Preferred Stock pursuant to the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum Purchase Agreement and Articles after July 1, 2015PIK Shares;
(d) Issue, incur or obligate itself to create, issue or issue of incur any debenture or any obligation indebtedness that is convertible into, any securities convertible intoor exchangeable for, any option to purchase or subscribe for, or warrants exercisable for, Shares equity security of the Company (other than grant stock options to employees Corporation or consultant as ESOP pursuant to this Agreement)instruments derivative of any equity security of the Corporation;
(e) Grant any rights to purchase require a mandatory repurchase, retirement or redeem redemption by the Corporation of any of the Corporation’s equity securities or pay any dividend instruments derivative of its equity securities on any capital stock or prior to the Series A Preference SharesRequired Redemption Date, or issue, incur or obligate the Series B Preference Shares Corporation to issue or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection incur, any indebtedness with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call maturity date on or forfeit any Shares held by BlueFocus representing prior to the unpaid Residual Amount (if any) in accordance with Required Redemption Date that is convertible into, or exchangeable for, equity securities or instruments derivative of the Memorandum and Articles after July 1, 2015Corporation’s equity securities;
(f) to create Effect an exchange, reclassification, or authorize the creation cancellation of any debt security (other than equipment leases all or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval a part of the Series A DirectorB1 Preferred Stock (except pursuant to Section 5.3 hereof, which shall not require any approval or consent of the Series B Director and the Series D DirectorHolders);
(g) to increase Effect an exchange, or decrease the size create a right of exchange, of all or part of the Board;shares of another class of shares into shares of Series B1 Preferred Stock (except pursuant to Section 5.3 hereof, which shall not require any approval or consent of the Holders); Vertex Energy: Series B1 Certificate of Designation 25
(h) Issue any shares of Series B1 Preferred Stock other than pursuant to approve any change in the business scope Purchase Agreement or activities of the Companyas PIK Shares;
(i) Alter or change the rights, preferences or privileges of the shares of Series B1 Preferred Stock so as to take actions subject to other protective provisions to be set forth in affect adversely the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;shares of such series; or
(j) to approve and change Amend or waive any compensation package provision of the management Corporation’s Articles of the Company, including but not limited Incorporation or Bylaws relative to the chief executive officer, general manager, and Series B1 Preferred Stock so as to affect adversely the shares of Series B1 Preferred Stock in any material respect as compared to holders of other key employee; and
(k) to agree or undertake to do any series of the foregoingshares.
Appears in 1 contract
Protective Provisions. 10.1 Approval (a) The holders of Series A the Preference SharesShares shall have the following consent rights (“Protective Provisions”), Series B Preference Shareswhich shall be subject to a vote at a Special General Meeting of the shareholders of the Company:
(b) Subject to Bye-law 3(b)(v)(c), Series D Preference Shares. For for so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 at least 4,056,978 Preference Shares (subject to adjustments made as adjusted for share splitconsolidations, subdivisionsubdivisions, consolidationshare dividends, reorganization redesignations, reclassifications, recapitalizations and the like events), like) remain in addition to any other vote or consent required elsewhere in the Memorandum and Articles or by applicable Lawissue, the Company shall not, and Members without first obtaining the Requisite Approval, engage in any of the following:
(i) any action that authorizes, creates or issues any shares having preferences superior to or on a parity with the any series of Preference Shares;
(ii) any amalgamation, consolidation, acquisition or similar transaction of the Company shall procure that with one or more other companies in which the shareholders of the Company and each prior to such transaction, or series of its Subsidiaries shall not (directly or by amendmentrelated transactions, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take any would hold shares representing less than a majority of the following actions voting power of the issued shares of the surviving company immediately after such transaction or series of transactions;
(iii) any acquisition or divestiture of assets (including, without limitation, intellectual property assets) other than licensing of intellectual property in the ordinary course of business and sale leasebacks (other than those in connection with a Non-Liquidation M&Asale leasebacks of intellectual property) without the prior vote and sales of equity or written consent of the holders of at least 50% of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately as a single class.
similar financing transactions (a) to liquidate, dissolve having a value of greater than fifty million United States Dollars (USD 50,000,000) or wind up (b) with any affiliate or shareholder of the affairs Company if such acquisition or divestiture has a value of greater than twenty-five million United States Dollars (USD 25,000,000);
(iv) the sale of all or substantially all of the Company, or effect any Liquidating Transaction’s assets (“ Sale Event”);
(bv) to amendthe liquidation, alter, dissolution or repeal any provision winding up of the Memorandum and ArticlesCompany;
(cvi) to create the declaration or authorize payment of a dividend on the creation Ordinary Class Shares (other than a dividend payable solely in Ordinary Class Shares) or redemption or repurchase of Ordinary Class Shares or issue any other security convertible into or exercisable for any equity securitypreference shares senior to, having rights, preferences or privileges senior junior to or on parity with the Series A Preference Shares, the or Series B Preference Shares or the Series D Preference Shares, or increase the authorized number of shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) except in accordance with obligations existing at the time of the issuance of such shares pursuant to compensation, equity incentive and other employment arrangements, or lending or equipment lease financing or similar transactions referred to in the Memorandum and Articles after July 1, 2015Bye-law 3(b)(iii)(l)(iv)(D) hereof;
(vii) except in the circumstances set out in Bye-laws 3(b)(i)(c) or (d) to create, or issue of any debenture or any obligation convertible into), any securities convertible into, any option to purchase increase or subscribe for, or warrants exercisable for, Shares decrease in the authorised number of Directors of the Company (provided, that the approval required for such action shall be the Requisite Approval without taking into account Preference Shares other than grant stock options to employees or consultant as ESOP pursuant to this AgreementVoting Preference Shares);
(eviii) the incurrence of any Indebtedness (as defined in the Amended and Restated Credit Agreement, dated as of December 21, 2000, among Stratus Computer (DE), Inc., a Delaware corporation, Stratus Technologies International S.à.▇.▇. (formerly known as Stratus Computer Systems S.à.▇.▇.), a company organized under the laws of Luxembourg, the several lenders from time to purchase or redeem or pay any dividend time parties thereto, the JPMorgan Chase Bank (formerly known as Chase Manhattan Bank), a New York banking corporation, as administrative agent for the lenders, and the other parties thereto, as amended (“Credit Agreement”)) by the Company and its subsidiaries in an aggregate amount greater than fifty million United States Dollars (USD 50,000,000) in excess of the amount outstanding and available to be drawn under the Credit Agreement, unless, after giving effect to the incurrence of such Indebtedness, the ratio of Indebtedness to EBITDA (based on any capital stock the twelve months ending prior to the Series A Preference Shares, the Series B Preference Shares month in which such calculation was made) is less than or the Series D Preference Shares equal to three (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any3) in accordance with the Memorandum and Articles after July 1, 2015times EBITDA;
(fix) to create or authorize the creation of an increase, in any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package of the management financial year of the Company, including but not limited in the number of options made available pursuant to the chief executive officer, general manager, and any other key employee; and
Option Pool in excess of two percent (k2%) to agree or undertake to do any of the foregoingmaximum number of options (without regard to outstanding or exercised options) issuable pursuant to the Option Pool, as the same may have been increased in accordance with this Bye-law 3(b)(v)(b)(ix).
Appears in 1 contract
Sources: Second Lien Credit Agreement (Stratus Technologies Bermuda Holdings Ltd.)
Protective Provisions. 10.1 Approval of So long as the Series A Preference Shares, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares Preferred Stock represents a minimum of twenty percent (subject to adjustments made for share split, subdivision, consolidation, reorganization and 20%) of the like events), in addition to any other vote or consent required elsewhere in outstanding capital stock of the Memorandum and Articles or by applicable LawCorporation, the Company Corporation shall not, and Members of the Company shall procure that the Company and each of its Subsidiaries shall not (directly or in any case, by amendment, merger, consolidation, amalgamation, scheme operation of arrangement law or otherwise) take any ), without first having provided written notice of such proposed action to each holder of outstanding shares of the following actions (other than those in connection with a Non-Liquidation M&A) without Series A Preferred Stock and having obtained the prior vote or written consent approval of the holders of at least 50% a majority of the then outstanding shares of Series D Preference SharesA Preferred Stock, given in writing or by consent or vote at a meeting:
(1) altering, changing or amending the preferences, privileges or rights of the Series A Preferred Stock or the Certificate of Incorporation or Bylaws in a manner which is adverse to the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately as a single class.
(a) to liquidate, dissolve or wind up the affairs of the Company, or effect any Liquidating TransactionPreferred;
(b2) to amend, alter, increase or repeal any provision of the Memorandum and Articles;
(c) to create or authorize the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, or increase decrease the authorized number of shares of any series of Preferred Stock;
(3) approve any transaction or series of transactions deemed to be a liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary;
(4) approve any Deemed Liquidity Event or other corporate reorganization or acquisition; or
(5) declare or pay any dividend or distribution or approve any repurchase with respect to the Series A Preference SharesPreferred (except as otherwise provided in Section 2 above) or the Common Stock (other than required redemptions and repurchases under restricted stock agreements or stock option agreements with employees, advisors, consultants and others and other arrangements approved by the Board of Directors). Further, the Series B Preference Shares Corporation shall not, by amendment, alteration or repeal of this Certificate of Incorporation (whether by merger, consolidation, operation of law, or otherwise) or through any Deemed Liquidity Event, or any other reorganization, recapitalization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities, agreement or any other voluntary action, avoid or seek to avoid the Series D Preference Shares observance or do performance of any act which has of the effect terms to be observed or performed hereunder by the Corporation and shall at all times in good faith assist in the carrying out of diluting all the provisions of this Section 4(d) and in the taking of all such action as may be necessary or reducing appropriate in order to protect the effective shareholding rights of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval each series of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package of the management of the Company, including but not limited to the chief executive officer, general manager, and any other key employee; and
(k) to agree or undertake to do any of the foregoingPreferred Stock against impairment.
Appears in 1 contract
Sources: Series a Preferred Stock Subscription Agreement (iSpecimen Inc.)
Protective Provisions. 10.1 Approval At any time when shares of Series A Preference SharesPreferred Stock are outstanding (provided, that, if a Mandatory Redemption Notice has been given, and any shares of Series B Preference SharesA Preferred Stock thereafter remain outstanding, or on and after a Redemption Failure, all shares of Series D Preference Shares. For so long as BertelsmannA Preferred Stock which have been redeemed, Sumitomo if any, shall for purposes of determining whether either of the conditions set forth in this sentence are met, be deemed outstanding) and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares convertible into shares of Common Stock equal to at least ten percent (subject to adjustments made for share split, subdivision, consolidation, reorganization and 10.0%) of the like eventsvoting power of the Corporation’s Common Stock (on a fully diluted basis), or at any time when the Requisite Investors collectively hold at least thirty-three percent (33.0%) of the aggregate amount of Series A Preferred Stock issued to the Requisite Investors on the Original Issuance Date, the Corporation shall not, and shall not permit any of its subsidiaries to, and neither the Corporation nor any subsidiary shall enter into any agreement to, either directly or indirectly, by amendment, merger, consolidation or otherwise, do any of the following without (in addition to any other vote required by law or consent required elsewhere in this Certificate of Incorporation) the Memorandum and Articles or by applicable Law, the Company shall not, and Members of the Company shall procure that the Company and each of its Subsidiaries shall not (directly or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take any of the following actions (other than those in connection with a Non-Liquidation M&A) without the prior vote or written consent or affirmative vote of the holders of at least 50% a majority of the then outstanding Series D Preference Shares, the holders shares of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference SharesPreferred Stock given in writing or by vote at a meeting, each consenting or voting (as the case may be) separately as a single class., and any such act or transaction entered into without such consent or vote shall be null and void ab initio, and of no force or effect:
(a) to i. liquidate, dissolve or wind wind-up the business and affairs of the CompanyCorporation or any operating subsidiary, effect any merger, consolidation or Deemed Liquidation Event of the Corporation or any operating subsidiary of the Corporation or consummate or agree to make any sale, transfer, assignment, pledge, lease, license, acquisition (other than the acquisition of a Person, business or interest therein, whether by acquisition of assets or securities, merger, consolidation, joint venture, business combination or otherwise, that has positive consolidated earnings, before interest, taxes, depreciation and amortization (each of the foregoing calculated in accordance with U.S. generally accepted accounting principles consistently applied) for the twelve calendar month period ending with the last full calendar month immediately preceding the calculation thereof, and in which shares of Common Stock, Options or Convertible Securities issued to such third party (or its equity holders) as acquisition consideration, if any, represent less than ten percent (10.0%) of the Corporation’s then outstanding Common Stock (on a fully diluted basis)), or effect similar transaction by which the Corporation or any Liquidating Transactionsubsidiary of the Corporation grants on an exclusive basis any rights to any of the Corporation’s or any of a Corporation’s subsidiary’s intellectual property, or consent to any of the foregoing, except for a Deemed Liquidation Event in which the holders of Series A Preferred Stock shall indefeasibly receive for each of their shares of Series A Preferred Stock upon the consummation thereof, an amount in cash not less than the Redemption Price (provided, however, that in no event, irrespective of whether consent is given under this subsection i, shall the Corporation be relieved of, nor shall the holders of Series A Preferred Stock be deemed to have waived, the Corporation’s obligation to redeem all outstanding shares of Series A Preferred Stock and pay the Redemption Price in accordance with Section A.3.c);
(b) to ii. amend, alter, alter or repeal any provision of this Certificate of Incorporation or Bylaws in a manner that adversely affects the Memorandum and Articlespowers, preferences or rights of the Series A Preferred Stock, it being understood that the authorization, issuance, conversion, reclassification, exchange or amendment of a new or existing class or series of capital stock that is, or that is convertible into, capital stock that is pari passu or senior to the powers, privileges, preferences, rights or otherwise, of the Series A Preferred Stock shall be deemed to adversely affect the powers, preferences or rights of the Series A Preferred Stock;
(ca) to create (i) create, or authorize the creation of of, or issue or obligate itself to issue shares of, any other security convertible into additional class or exercisable for any equity security, having rights, preferences or privileges senior series of capital stock of the Corporation unless the same (x) ranks junior to or on parity with the Series A Preference SharesPreferred Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation or upon a Deemed Liquidation Event, the payment of dividends and rights of redemption and (y) is issued at fair market value as reasonably and in good faith determined by the Board, or (ii) increase the authorized number of shares of Series B Preference Shares or the Series D Preference Shares, A Preferred Stock (except as provided in Section A.5.c.i) or increase the authorized number of shares of any additional class or series of capital stock of the Corporation, unless the same ranks junior to the Series A Preference SharesPreferred Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation or upon a Deemed Liquidation Event, the payment of dividends and rights of redemption or (b) create, or authorize the creation of, or issue or obligate itself to issue shares of, any additional class or series of capital stock of any subsidiary of the Corporation;
iv. [intentionally omitted];
v. purchase or redeem (or permit any subsidiary to purchase or redeem) or pay, declare or set aside any fund for, any dividend or distribution on, any Junior Stock, other than purchases of Equity Securities upon the termination of an employee of the Corporation or any of its subsidiaries in accordance with the terms of such employee’s employment agreement or any equity incentive or similar plan approved by the Board;
vi. issue any shares of Series B Preference Shares A Preferred Stock to any individual, entity or other person other than to the Series D Preference Shares Requisite Investors, and any transferees thereof;
vii. create, incur, grant, enter into, permit, assume or do suffer to exist, directly or indirectly, (i) any act which indebtedness by the Corporation (or any of its subsidiaries) or otherwise issue any Debt Securities at any time when, or as a result of which, the principal amount of the Corporation’s total outstanding and available indebtedness and Debt Securities exceeds the product of (x) three (3) multiplied by (y) the consolidated earnings, before interest, taxes, depreciation and amortization of the Corporation and its subsidiaries (each of the foregoing calculated in accordance with U.S. generally accepted accounting principles) for the twelve calendar month period ending with the last full calendar month immediately preceding the calculation thereof, (ii) any lien, charge or other encumbrance on any of the Corporation’s (or any of its subsidiaries’) properties or assets other than Permitted Liens (as defined in the Purchase Agreement), or (iii) guaranty the obligations of any third party;
viii. take any actions to, or that has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Sharesa, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) change in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board to a number other than seven (7) directors;
ix. take any actions to relocate, or relocate, the principal executive offices of the Corporation outside of the United States;
x. enter into any arrangement with any Affiliate or Associate of the Corporation or any subsidiary of the Corporation, or modify any existing arrangement between the Corporation and any of its Affiliates or Associates or an existing arrangement between any subsidiary of the Corporation and any of its Affiliates or Associates, except for transactions (x) solely between or among two or more of the Corporation and any of its wholly-owned subsidiaries or (y) the terms and conditions of which have been determined by the Board to be no less favorable in any material respect to the Corporation or any subsidiary of the Corporation than those terms and conditions that would be obtained on an arm’s length basis and that does not provide for, or is not reasonably likely to result in, aggregate payments to or by the Corporation or any subsidiary of the Corporation in excess of $1,000,000; provided that the provisions of this subsection x shall not apply to customary director, officer, employee and consultant compensation (including bonuses) and other employment benefits (including retirement, health, stock and other benefit plans) and indemnification and insurance arrangements approved by the Board;
(h) to approve xi. take any change in the business scope actions to, or activities otherwise, amend, modify, repeal or enter any waiver of the Company;[_]1, or enter into or consummate any replacement, substitution or refinancing thereof; or
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financingxii. agree to, the Series B financing commit to, resolve to, or the Series D financing;
(j) to approve and change otherwise enter into any compensation package of the management of the Company, including but not limited to the chief executive officer, general manager, and any other key employee; and
(k) to agree or undertake agreement to do any of the foregoing. For the avoidance of doubt, any action that is permitted under one or more of the above subsections i-xii of this Section A.4.c, but is not permitted under any other of such subsections shall nevertheless require consent as described in this Section A.4.c under such other subsections.
Appears in 1 contract
Sources: Investment and Transaction Agreement (Id Systems Inc)
Protective Provisions. 10.1 Approval Subject to the rights of series of Preferred Stock which may from time to time come into existence, so long as any shares of Series A Preference SharesPreferred Stock are outstanding, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in addition to any other vote or consent required elsewhere in the Memorandum and Articles or by applicable Law, the Company shall not, and Members of the Company shall procure that the Company and each of its Subsidiaries this corporation shall not without first obtaining the approval (directly or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take any of the following actions (other than those in connection with a Non-Liquidation M&A) without the prior vote or written consent consent, as provided by law) of the holders of at least 50% two thirds (66.67%) of the then outstanding Series D Preference Shares, the holders shares of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately as a single class.Preferred Stock:
(a) to liquidatesell, dissolve convey, or wind up otherwise dispose of or encumber all or substantially all of its property or business or merge with and into any other corporation where the affairs of corporation is not the Companysurviving corporation (other than a wholly-owned subsidiary corporation), or effect any Liquidating Transaction;transaction or series of related transactions in which more than fifty percent (50%) of the voting power of the corporation is disposed of, or effect any voluntary liquidation, dissolution or winding up of the corporation or recapitalization of the corporation; or
(b) to amendalter or change the rights, alter, preferences or repeal any provision privileges of the Memorandum and Articles;shares of Series A Preferred Stock so as to adversely affect such shares; or
(c) increase or decrease (other than by redemption or conversion) the total number of authorized shares of capital stock or any series of capital stock, provided, however, that no such approval shall be required to create increase the total number of authorized shares of Common Stock to less than or equal to fifteen million (15,000,000) shares; or
(d) authorize the creation of or issue issue, or obligate itself to issue, any equity security, including any other security convertible into or exercisable for any equity security, (i) having a preference over, or being on a parity with, the rights, preferences or and privileges senior to or on parity with of the Series A Preference SharesPreferred Stock with respect to dividends, liquidation or voting (provided that additional shares of Common Stock having the same number of votes per share as the Series B Preference Shares A Preferred Stock may be issued), or (ii) having rights similar to any of the rights of the Series A Preferred Stock under this Section 8; or
(e) redeem, purchase or otherwise acquire (or pay into or set aside for a sinking fund for such purpose) any share or shares of Common Stock; provided, however, that this restriction shall not apply to the repurchase of shares of Common Stock from certain shareholders pursuant to that certain Shareholder Agreement dated June 8, 1994 or that certain Shareholders' Agreement dated on or about February 12, 1998 or the Series D Preference Sharesrepurchase of shares of Common Stock from employees, officers, directors, consultants or other persons performing services for the corporation or any subsidiary pursuant to agreements under which the corporation has the option to repurchase such shares at cost upon the occurrence of certain events, such as the termination of employment; or
(f) issue, or obligate itself to issue, greater than 533,333 shares of Series A Preferred Stock; or
(g) pay any dividends on the corporation's Common Stock; or
(h) amend the corporation's Articles of Incorporation, provided, however, that no such approval shall be required for an amendment to the corporation's Articles of Incorporation to increase the total number of authorized shares of Common Stock to less than or equal to fifteen million (15,000,000) shares; or (i)ab increase the authorized number of shares directors of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount corporation to more than thirteen (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement13);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package of the management of the Company, including but not limited to the chief executive officer, general manager, and any other key employee; and
(k) to agree or undertake to do any of the foregoing.
Appears in 1 contract
Sources: Series a Preferred Stock Purchase Agreement (Pemstar Inc)
Protective Provisions. 10.1 Approval (a) So long as at least 6,450,000 Series A Preferred Shares (as adjusted for any share split, share dividend, share combination or consolidation, recapitalization, reclassification or other similar event) shall be outstanding, the Investors and Founders shall not, without obtaining the affirmative vote or written consent of the holders of a majority of the outstanding Series A Preferred Shares voting as a separate class (based on the number of Ordinary Shares into which each holder’s Series A Preferred Shares is then convertible, as adjusted from time to time), vote at a regular or special meeting of shareholders (or by written consent) to:
(i) waive, amend, or repeal any provision of the Company’s Articles of Association if such action would adversely alter or change the rights, preferences or privileges of, or the restrictions provided for the benefit of, the Series A Preferred Shares;
(ii) increase or decrease the authorized number of shares of Series A Preference Preferred Shares; or
(iii) create (by reclassification or otherwise) any new class or series of shares having rights, preferences or privileges senior to or on a parity with the Series A Preferred Shares.
(b) So long as at least 3,000,000 Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Preferred Shares (subject to adjustments made as adjusted for any share split, subdivisionshare dividend, share combination or consolidation, reorganization recapitalization, reclassification or other similar event) shall be outstanding, the Investors and the like events), in addition to any other vote or consent required elsewhere in the Memorandum and Articles or by applicable Law, the Company Founders (1) shall not, and Members without obtaining the affirmative vote or written consent of the holders of a majority of the outstanding Series B Preferred Shares voting as a separate class (based on the number of Ordinary Shares into which each holder’s Series B Preferred Shares is then convertible, as adjusted from time to time) vote at a regular or special meeting of shareholders (or by written consent) of the Company to and (2) in the case of (i), (iii), (iv), (v) and (vi) below, shall procure that the Company and each of its Subsidiaries the other Group Members shall not (directly or by amendmentnot, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take any of without obtaining the following actions (other than those in connection with a Non-Liquidation M&A) without the prior affirmative vote or written consent of the holders of at least 50% a majority of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Preferred Shares and voting as a separate class (based on the holders number of Ordinary Shares into which each holder’s Series B Preferred Shares is then convertible, as adjusted from time to time), vote at least 50% a regular or special meeting of shareholders (or by written consent) of the then outstanding Series A Preference Shares, each voting separately as a single class.Group Member that it owns to:
(ai) to liquidatewaive, dissolve or wind up the affairs of the Company, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum articles of association or any other charter documents of such Group Member if such action would adversely alter or change the rights, preferences or privileges of, or the restrictions provided for the benefit of, the Series B Preferred Shares;
(ii) increase or decrease the authorized number of shares of Series B Preferred Shares;
(iii) create (by reclassification, merger or otherwise) any new class or series of shares having rights, preferences or privileges with respect to dividends, or payments upon liquidation senior to or on a parity with the Series B Preferred Shares or having voting rights other than those granted to the Preferred Shares generally;
(iv) take any action that would expose the holders of Series B Preferred Shares to more than a minimal risk of being subject to taxation under Section 305 of the United States Internal Revenue Code;
(v) redeem or repurchase any of the Company’s shares or declare a dividend with respect to any such shares; provided, however, that this provision shall not apply to the Company’s redemption or repurchase of shares issued to or held by employees, officers, directors or consultants of the Company upon termination of their employment or services or pursuant to agreements providing for the right of such repurchase between the Company and Articlessuch persons;
(vi) change the number of directors constituting the full Board and the board of directors of each of the Offshore Group Members; or
(vii) amend Article 51(3)(e)(ii) of the Company’s Articles of Association.
(c) So long as at least 3,000,000 of the Series C Preferred Shares (as adjusted for any share split, share dividend, share combination or consolidation, recapitalization, reclassification or other similar event) shall be outstanding, the Investors and the Founders (1) shall not, without obtaining the affirmative vote or written consent of the holders of at least two thirds (2/3) of the outstanding Series C Preferred Shares voting as a separate class (based on the number of Ordinary Shares into which each holder’s Series C Preferred Shares is then convertible, as adjusted from time to time), vote at a regular or special meeting of shareholders (or by written consent) of the Company to, and (2) in the case of (i), (iii), (iv), (v) and (vi) below, shall procure that each of the other Group Members shall not, without obtaining the affirmative vote or written consent of the holders of at least two-thirds (2/3) of the outstanding Series C Preferred Shares voting as a separate class (based on the number of Ordinary Shares into which each holder’s Series C Preferred Shares is then convertible, as adjusted from time to time), vote at a regular or special meeting of shareholders (or by written consent) of the Group Member that it owns to:
(i) waive, amend, or repeal any provision of the articles of association or any other charter documents of such Group Member if such action would adversely alter or change the rights, preferences or privileges of, or the restrictions provided for the benefit of, the Series C Preferred Shares;
(ii) increase or decrease the authorized number of shares of Series C Preferred Shares;
(iii) create (by reclassification, merger or authorize the creation of otherwise), offer or issue any other security convertible new class or series of shares, or any securities or rights to acquire or convert into any such class or exercisable for any equity securityseries of shares, having rights, preferences or privileges (including but not limited to with respect to dividends or payments upon liquidation) senior to or on a parity with the Series A Preference SharesC Preferred Shares or having voting rights other than those granted to the Preferred Shares generally;
(iv) take any action that would expose the holders of Series C Preferred Shares to more than a minimal risk of being subject to taxation under Section 305 of the United States Internal Revenue Code;
(v) declare a dividend with respect to any of its shares or any other payment to the holders of its shares in their capacity as shareholders out of its distributable profits or reserves of the relevant Group Member;
(vi) change the number of directors constituting the full Board and the board of directors of each of the Offshore Group Members; or
(vii) amend Article 51(3)(e)(iii) of the Company’s Articles of Association.
(d) So long as at least 3,000,000 of the Series D Preferred Shares (as adjusted for any share split, share dividend, share combination or consolidation, recapitalization, reclassification or other similar event) shall be outstanding, the Investors and the Founders (1) shall not, without obtaining the affirmative vote or written consent of the holders of at least two thirds ( 2/3) of the outstanding Series D Preferred Shares voting as a separate class (based on the number of Ordinary Shares into which each holder’s Series D Preferred Shares is then convertible, as adjusted from time to time), vote at a regular or special meeting of shareholders (or by written consent) of the Company to and (2) in the case of (i), (iii), (iv), (v) and (vi) below, shall procure that each of the other Group Members shall not, without obtaining the affirmative vote or written consent of the holders of at least two-thirds ( 2/3) of the outstanding Series D Preferred Shares voting as a separate class (based on the number of Ordinary Shares into which each holder’s Series D Preferred Shares is then convertible, as adjusted from time to time), vote at a regular or special meeting of shareholders (or by written consent) of the Group Member that it owns to:
(i) waive, amend, or repeal any provision of the articles of association or any other charter documents of such Group Member if such action would adversely alter or change the rights, preferences or privileges of, or the restrictions provided for the benefit of, the Series B Preference Shares D Preferred Shares;
(ii) increase or the Series D Preference Shares, or increase decrease the authorized number of shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Preferred Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(diii) to createcreate (by reclassification, merger or otherwise), offer or issue any new class or series of shares, or issue of any debenture or any obligation convertible into, any securities convertible intoor rights to acquire or convert into any such class or series of shares, any option to purchase having rights, preferences or subscribe for, or warrants exercisable for, Shares of the Company privileges (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package of the management of the Company, including but not limited to with respect to dividends or payments upon liquidation) senior to or on a parity with the chief executive officer, general manager, and Series D Preferred Shares or having voting rights other than those granted to the Preferred Shares generally;
(iv) take any action that would expose the holders of Series D Preferred Shares to more than a minimal risk of being subject to taxation under Section 305 of the United States Internal Revenue Code;
(v) declare a dividend with respect to any of its shares or any other key employee; andpayment to the holders of its shares in their capacity as shareholders out of distributable profits or reserves of the relevant Group Member;
(kvi) to agree or undertake to do any change the number of directors constituting the full Board and the board of directors of each of the foregoingOffshore Group Members; or
(vii) amend Article 51(3)(e)(iv) of the Company’s Articles of Association.
Appears in 1 contract
Sources: Investor Rights Agreement (Ambow Education Holding Ltd.)
Protective Provisions. 10.1 Approval 3.2.1 At any time when any Convertible Preferred Shares remain outstanding, the Company shall not, either directly or indirectly (including through a subsidiary) by amendment, merger, consolidation or otherwise, do any of Series A Preference Shares, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares the following without (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in addition to any other vote required by law or consent required elsewhere in the Memorandum and Articles (or by applicable Law, the Company shall not, and Members any certificate of designation relating to any series of the Company shall procure that the Company and each of its Subsidiaries shall not (directly or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwisePreferred Shares)) take any of the following actions (other than those in connection with a Non-Liquidation M&A) without the prior vote or written consent of the holders of at least 50% two-thirds of the then outstanding Series D Preference Convertible Preferred Shares (and for the avoidance of doubt, any of the actions prohibited by or taken in contravention of this Section 3.2.1 shall be ultra ▇▇▇▇▇, null and void ab initio and of no force or effect) (provided, that this Section 3.2.1 shall not prohibit the Company from effecting a transaction solely to change the domicile of the holding company of the Company and its subsidiaries to the state of Delaware so long as (x) the Convertible Preferred Shares, the holders Ordinary Shares and any other classes or series of at least 50% shares of the then Company outstanding Series B Preference Shares immediately prior to such transaction are exchanged for preferred stock in such holding company having powers, rights, preferences, privileges and the holders of at least 50% restrictions substantially identical to those of the then outstanding Series A Preference Convertible Preferred Shares, each voting separately Ordinary Shares or such other classes or series, as the case may be, immediately prior to such transaction, (y) there is no other class or series of shares or other equity securities in such holding company outstanding immediately following such transaction and (z) and such holding company is a single class.Delaware corporation):
(a) to liquidate, dissolve or wind up the affairs of the Company, or effect any Liquidating Transaction;
(b) to amend, alter, alter or repeal any provision of the Memorandum and Articles;
Articles (cor any certificate of designation relating to any series of Preferred Shares), as then in effect, in a manner adverse to the powers, rights, preferences, restrictions or privileges of the Convertible Preferred Shares; (b) (i) issue Convertible Preferred Shares (or any securities convertible into or exercisable or exchangeable for Convertible Preferred Shares) after the Original Issue Date, (ii) without limiting clause (v) below, issue any Preferred Shares (other than Convertible Preferred Shares) unless the Articles are first amended to amend Article 8.1 thereof in a manner reasonably acceptable to holders of at least 2/3 of the then-outstanding Convertible Preferred Shares; (iii) increase the authorized number of Convertible Preferred Shares; (iv) reclassify any Ordinary Shares or Preferred Shares to give those shares a preference or priority as to dividends or assets or property superior to any existing series of Preferred Shares; or (v) create or authorize the creation of of, increase the authorized amount of, or allot or issue (A) any other class or series of shares that have, or any security convertible into or exercisable or exchangeable for any equity securityclass or series of shares where the underlying shares have, having rights, preferences or privileges that are senior to to, superior to, or on parity, in any respect, with the Convertible Preferred Shares (provided, however that, for the avoidance of doubt, Ordinary Shares or securities that are convertible or exchangeable into Ordinary Shares shall not be deemed on parity with the Series A Preference Shares, Convertible Preferred Shares solely because the Series B Preference Convertible Preferred Shares vote with or participate in dividends and distributions with the Series D Preference Shares, Ordinary Shares on an as-converted basis) or increase the authorized number (B) any class or series of shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe that provide for, or warrants any security convertible into or exercisable or exchangeable for any class or series of shares where the underlying shares provide for, Shares mandatory redemption or repurchase of such shares by the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to excluding, for the Series A Preference Sharesavoidance of doubt, the Series B Preference conversion of such shares into Ordinary Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) to take actions subject to other protective provisions deemed to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package a repurchase of the management of the Company, including but not limited to the chief executive officer, general manager, and any other key employeesuch converted shares); and
(k) to agree or undertake to do any of the foregoing.or
Appears in 1 contract
Sources: Securities Purchase Agreement (SMART Global Holdings, Inc.)
Protective Provisions. 10.1 Approval of Series A Preference Shares, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in In addition to any such other vote or consent required elsewhere limitations as may be provided in the Memorandum and Articles or by applicable Lawand the BVI Business Companies ▇▇▇ ▇▇▇▇, the Company shall not, and Members shall cause the other Group Companies to not, and the holders of Ordinary Shares shall exercise all of their rights with respect to such Ordinary Shares so as to cause the Company shall procure that the Company and each of its Subsidiaries shall not (directly Group Companies to not, effect or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take otherwise consummate any of the following actions acts without first obtaining,
(other than those in connection with a Non-Liquidation M&A1) without the prior vote or written consent approval of (i) the holder(s) of at least 75% of the holders outstanding Series A Shares and Series A1 Shares (in aggregate and on an as-converted basis), and (ii) the holder(s) of at least 50% of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% (on an as converted basis); provided that such requirement shall terminate upon a Qualified Public Offering:
i. any amendment or change of the then outstanding Series A Preference Sharesrights, each voting separately as a single class.
(a) to liquidatepreferences, dissolve privileges or wind up the affairs of the Companypowers of, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum and Articles;
(c) to create or authorize restrictions provided for the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Sharesbenefit of, the Series B Preference Preferred Shares or the Series D Preference Shares, or increase the authorized number of shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) ii. any action to take actions subject authorize, create or issue shares of any class or series of the Company having preferences superior to other protective provisions to be set forth in the definitive agreements in connection or on a parity with the Series A financingPreferred Shares in any aspects including without limitation, the Series B financing or the Series D financingdividend rights, redemption rights and/or liquidation rights;
(j) to approve and change iii. any compensation package new issuance of the management any equity securities of the Company, including any change in the total number of authorized Series B Shares, but not limited excluding (i) any issuance of the Series B Shares authorized under the Purchase Agreement, (ii) any issuance of Ordinary Shares upon conversion of the Preferred Shares, and (iii) the issuance of 66,580 Ordinary Shares reserved for issuance upon the exercise of the option currently held by Winsome Group Limited on behalf of Ma ▇▇▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ Ho, Ma Wen Lie, ▇▇▇▇ Lo Yin and other officers, employees and advisors of the Company, and (iv) the issuance of up to 151,430 Ordinary Shares (and/or options or warrants therefor) reserved for issuance pursuant to the chief executive employee equity incentive plans approved by the Compensation Committee (as defined in the Articles);
iv. any action of the Company to reclassify any outstanding shares into shares having preferences or priority as to dividends or assets senior to or on a parity with the preference of the Preferred Shares;
v. any increase or decrease of the authorized number of Ordinary Shares or Preferred Shares of the Company;
vi. any amendment of the Memorandum and Articles of Association or other charter documents of the Company (including any Major Subsidiary);
vii. any merger or consolidation of the Company (including any Subsidiary) with or into any other business entity in which the shareholders of the Company (including any Subsidiary) immediately after such merger or consolidation held shares representing less than a majority of the voting power of the outstanding share capital of the surviving business entity;
viii. any transaction or series of transactions that would result in a change of control of the Company (including any Subsidiary);
ix. the sale, lease, transfer or other disposition of all or substantially all of the assets of the Company (including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries;
x. any licensing or other transfer of the patents, copyrights, trademarks or other intellectual property of the Company (including any Subsidiary) other than in the ordinary course of its business, except for intra-group transactions among the Company and any Subsidiaries;
xi. any increase or decrease of the authorized number of the Board (including any committees of the Board) of the Company;
xii. effect a liquidation, dissolution or winding up of the Company (including any Subsidiary)
xiii. the declaration or payment of a dividend or other distribution on Ordinary Shares or Preferred Shares of the Company;
xiv. any increase of the number of Ordinary Shares of the Company reserved under any employee equity incentive plan;
xv. any increase in compensation of any employee of the Company (including any Subsidiary) with an annual salary of US$50,000 or more by more than 20% in a twelve (12) month period;
xvi. the extension by the Company of any loan or guarantee for indebtedness to any director, officer, general manageremployee or affiliate of the Company (Including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries;
xvii. any incurrence of indebtedness in excess of US$1,000,000 in the aggregate to the Company (Including any Subsidiary), or creation of any encumbrance whatsoever upon the assets, patents, copyrights, trademarks or other intellectual property of the Company (including any Subsidiary);
xviii. any purchase by the Company (including any Subsidiary) of real property with a value of US$1,000,000 or more, or any purchase of production facilities with a value of US$500,000 or more, individually or in the aggregate;
xix. any transaction or series of transactions that are not in the ordinary course of the Company’s business where the value involved exceeds US$1,000,000, individually or in the aggregate, during any twelve (12) month period;
xx. approval of the annual consolidated budget of the Company;
xxi. the appointment and removal of any key employeeofficer of the Company (including any Major Subsidiary), including the Chief Executive Officer and the Chief Financial Officer;
xxii. the appointment and/or reappointment of auditors of the Company; or
xxiii. any transaction involving both the Company (including any Subsidiary) and a shareholder of any Group Company or any of the Company’s employees, officers, directors or shareholders or any affiliate of a shareholder of any Group Company or any of such affiliate’s officers, directors or shareholders, except for intra-group transactions among the Company and any Subsidiaries and employment contracts between a Group Company and its employees that are not otherwise subject to this paragraph 7.3(h), and
(k2) the prior written approval of the holder(s) as at the date hereof (taking no account of any share issuances after the date hereof) of at least 96% of the aggregate of Ordinary Shares and preferred Shares (on an as-converted basis), provided that such requirement shall terminate upon a Qualified IPO, any repurchase or redemption of any equity securities of the Company other than (A) pursuant to agree contractual rights to repurchase Ordinary Shares from the employees, directors or undertake consultants of the Company upon termination of their employment or services or (B) pursuant to do a contractual right of first refusal held by the Company. Provided, however that, to the extent that the applicable laws prevent the Company from being bound by any of the foregoingabove provisions, such provisions shall be binding as amongst the holders of Ordinary Shares and holders of Preferred Shares and such parties shall take all actions necessary to give effect to such provisions.
Appears in 1 contract
Protective Provisions. 10.1 Approval So long as the Lead Investor beneficially owns at least at least twenty percent (20%) of Series A Preference the Conversion Shares underlying the Preferred Shares issued pursuant to the Securities Purchase Agreement (assuming the full conversion of such Preferred Shares, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like eventsirrespective of any ownership limitations contained therein), in addition to any other vote or consent required elsewhere in the Memorandum and Articles or except as otherwise contemplated by applicable LawSection (2), the Company shall not, and Members of the Company shall procure that the Company and each of its Subsidiaries shall not (either directly or indirectly by amendment, merger, consolidation, amalgamationrecapitalization, scheme of arrangement reclassification, or otherwise) take , do any of the following actions without (in addition to any other than those in connection with a Non-Liquidation M&Avote required by law or the Company’s Amended and Restated Certificate of Incorporation) without the prior vote or written consent of the holders Lead Investor, and any such act or transaction entered into without such consent or vote shall be null and void ab initio, and of at least 50% of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately as a single class.no force or effect:
(a) to liquidateCreate, dissolve or wind up the affairs of the Company, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum and Articles;
(c) to create or authorize the creation of of, or issue or obligate itself to issue shares of, or reclassify, any other security convertible into or exercisable for any equity security, having capital stock unless the same ranks junior to the Preferred Shares with respect to its rights, preferences or privileges senior to or on parity with the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Sharesand privileges, or increase the authorized number of shares of the Series A Preference Shares, the Series B Preference Shares any class or the Series D Preference Shares or do any act which has the effect series of diluting or reducing the effective shareholding capital stock of the holders of Company unless the Series A Preference Sharessame ranks junior to the Preferred Shares with respect to its rights, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum preferences and Articles after July 1, 2015privileges;
(db) to createCreate, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of, or issue, or authorize the issuance of any debt security or create any lien or security interest (except for purchase money liens or statutory liens of landlords, mechanics, materialmen, workmen, warehousemen and other than equipment leases similar persons arising or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change incurred in the business scope ordinary course of business) or activities of the Company;
(i) to take actions subject to incur other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package of the management of the Companyindebtedness for borrowed money, including but not limited to obligations and contingent obligations under guarantees, or permit any Subsidiary to take any such action with respect to any debt security lien, security interest or other indebtedness for borrowed money, if the chief executive officeraggregate indebtedness of the Company and its Subsidiaries for borrowed money following such action would exceed $10,000,000, general managerother than equipment leases, and any other key employee; andequipment purchase money loans, trade payables, or a working capital line of credit with customary terms, in each case, entered into in the ordinary course;
(kc) Directly or indirectly engage in any material line of business substantially different from those lines of business conducted by or publicly contemplated to agree be conducted by the Company and each of its Subsidiaries on the Effective Date; provided, that the foregoing shall not prevent the Company and its Subsidiaries from engaging in any business that is reasonably related or undertake incidental or ancillary to do its or their business; or
(d) amend, alter or repeal any provision of the foregoingAmended and Restated Certificate of Incorporation or Bylaws of the Corporation in a manner that adversely affects the special rights, powers and preferences of the Preferred Stock.
Appears in 1 contract
Protective Provisions. 10.1 Approval of Series A Preference Shares, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in addition to any other vote or consent required elsewhere in the Memorandum and Articles or by applicable Law, the Company The Corporation shall not, and Members of the Company shall procure that the Company and each not permit any of its Subsidiaries shall not (to, directly or indirectly, without the affirmative vote (or written consent as permitted by amendmentthe DGCL, the Certificate of Incorporation and Bylaws) of the Requisite Holders, voting (or consenting) as a separate class:
(i) amend, alter, modify or repeal (whether by merger, consolidation, amalgamation, scheme of arrangement consolidation or otherwise) take this Certificate of Designations, the Certificate of Incorporation or the Bylaws in any manner that adversely affects the rights, preferences, privileges or the restrictions provided for the benefit of, the Series C Preferred Stock (in each case, including without limitation, changing the total number of Series C Preferred Stock that the Corporation shall have the authority to issue);
(ii) reclassify, alter or amend any securities of the Corporation or any Subsidiary in a manner that adversely affects the designations, preferences, powers and/or the relative participating, optional or other special rights, or the restrictions provided for the benefit of the Series C Preferred Stock;
(iii) in any manner authorize, create, designate, issue or sell any (A) class or series of capital stock (including shares of treasury stock) that would be classified as Senior Securities or Parity Securities or (B) rights, options, warrants or other securities (including debt securities) convertible into or exercisable or exchangeable for capital stock or any equity security or having any other equity feature, in each case, that would be classified as either Senior Securities or Parity Securities, except as may be necessary in connection with the declaration and payment of in-kind dividends to holders of outstanding shares of Series C Preferred Stock;
(iv) enter into, or become subject to, any agreement or instrument or other obligation which by its terms restricts the Corporation’s ability to perform its obligations under this Certificate of Designations, including the ability of the Corporation to pay dividends or make any redemption or other liquidation payment required hereunder;
(v) purchase or redeem (or permit any subsidiary to purchase or redeem) or pay or declare any dividend, or make any distribution on, any shares of capital stock of the Corporation, other than redemptions of or dividends or distributions on the Series C Preferred Stock or any dividend or other distribution that would qualify as a Participating Dividend, in each case as expressly authorized herein; or
(vi) enter into any agreement to do any of the following actions (other than those in connection with a Non-Liquidation M&A) without foregoing that is not expressly made conditional on obtaining the prior affirmative vote or written consent of the holders of at least 50% of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately as a single classRequisite Holders.
(a) to liquidate, dissolve or wind up the affairs of the Company, or effect any Liquidating Transaction;
(b) to amend, alter, or repeal any provision of the Memorandum and Articles;
(c) to create or authorize the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, or increase the authorized number of shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director and the Series D Director;
(g) to increase or decrease the size of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package of the management of the Company, including but not limited to the chief executive officer, general manager, and any other key employee; and
(k) to agree or undertake to do any of the foregoing.
Appears in 1 contract
Protective Provisions. 10.1 Approval 9.1 Subject to the rights of Series A Preference Sharesseries of preferred stock which may from time to time come into existence, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in addition to any other vote or consent required elsewhere in the Memorandum and Articles or by applicable Lawshares of Series B Preferred are outstanding, the Company Corporation shall not, and Members of without first obtaining the Company shall procure that the Company and each of its Subsidiaries shall not approval (directly or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take any of the following actions (other than those in connection with a Non-Liquidation M&A) without the prior vote or written consent or at a meeting duly called, each as provided by law) of the holders of at least 50% a Majority In Interest of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference SharesPreferred, each voting separately together as a single class.:
(a) Increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series B Preferred (except to liquidatethe extent required to issue PIK Shares if required by the terms set forth herein, dissolve or wind up which for the affairs sake of clarity, and without otherwise limiting this provision, shall not require approval of the Company, or effect any Liquidating TransactionHolders);
(b) Re-issue any shares of Series B Preferred converted pursuant to amend, alter, or repeal any provision the terms of the Memorandum and Articlesthis Designation;
(c) to create Create, or authorize the creation of of, or issue or obligate itself to issue shares of, any class or series of capital stock unless the same ranks junior to (and not pari passu with) the Series B Preferred with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the payment of dividends and rights of redemption, or increase the authorized number of shares of any additional class or series of capital stock unless the same ranks junior to (and not pari passu with) the Series B Preferred with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the payment of dividends and rights of redemption, in each such case, other than issuances of (or in connection with issuances of) shares of Series B Preferred pursuant to the Purchase and Sale Agreement, PIK Shares and the Series C Preferred Stock;
(d) Effect an exchange, reclassification, or cancellation of all or a part of the Series B Preferred (except pursuant to the terms hereof);
(e) Effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series B Preferred;
(f) Alter or change the rights, preferences or privileges of the shares of Series B Preferred so as to affect adversely the shares of such series;
(g) Authorize or issue, or obligate itself to issue, any other equity security, including any other security convertible into or exercisable for any equity security, security having rights, preferences or privileges senior to a preference over (or on parity with the Series A Preference Shares, with) the Series B Preference Shares Preferred with respect to liquidation; or
(h) Amend or waive any provision of the Corporation’s Articles of Incorporation or Bylaws, each as amended, relative to the Series D Preference SharesB Preferred so as to affect adversely the shares of Series B Preferred. For clarification, the creation or increase the authorized number issuance of shares of other series of preferred stock, provided the Series A Preference Sharesrights and preferences of such series of preferred stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the payment of dividends are not senior to the Series B Preference Shares Preferred Liquidation Preference, shall not require the authorization or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding approval of the holders of the Series A Preference SharesB Preferred.
9.2 The Corporation will not through any reorganization, transfer of assets, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the Series B Preference Shares observance or performance of any of the Series D Preference Shares, provided that, no vote terms to be observed or written consent under performed hereunder by the Corporation but will at all times in good faith assist in the carrying out of all the provisions of this Section shall Designation and in the taking of all such action as may be required from necessary or appropriate in order to protect (a) the Holder Conversion Rights of the Holders of Series D Shares before B Preferred; and (b) the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares other rights of the Company (other than grant stock options to employees or consultant Holders as ESOP pursuant to this Agreement);
(e) to purchase or redeem or pay any dividend on any capital stock prior to set forth herein, against impairment. Notwithstanding the Series A Preference Sharesforegoing, nothing shall prohibit the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased Corporation from former employees or consultants in connection amending its Articles of Incorporation with the cessation requisite consent of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval of the Board, including the approval of the Series A Director, the Series B Director its stockholders and the Series D Director;
(g) to increase or decrease the size Board of the Board;
(h) to approve any change in the business scope or activities of the Company;
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package of the management of the Company, including but not limited to the chief executive officer, general manager, and any other key employee; and
(k) to agree or undertake to do any of the foregoingDirectors.
Appears in 1 contract
Protective Provisions. 10.1 Approval In addition to such other limitations as may be provided in the Restated Memorandum and Articles, the following acts shall require (i) the prior written approval of the holder(s) of more than fifty percent (50%) of the Preferred Shares, in the event that any such matter set forth below is by applicable laws required to be determined by members of the Company; or (ii)the prior written approval of one or more Series A Preference Directors appointed by the holder(s) of more than fifty percent (50%) of the Preferred Shares, Series B Preference Shares, Series D Preference Shares. For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 Shares in the event that any such matter set forth below is by applicable laws required to be determined by the board of the Company:
(subject a) adoption or change to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in addition to any other vote or consent required elsewhere in the Memorandum and Articles of Association or by applicable Law, the Company shall not, and Members other charter documents of the Company shall procure that the Company and each of its Subsidiaries shall not (directly or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take any of the following actions (other than those in connection with a Non-Liquidation M&A) without the prior vote or written consent of the holders of at least 50% of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference Shares, each voting separately as a single class.
(a) to liquidate, dissolve or wind up the affairs of the Group Company, or effect any Liquidating Transaction;
(b) establishment of any board committee and the delegation of any authority to amend, alter, or repeal the Board of Directors of any provision of the Memorandum and ArticlesGroup Company;
(c) to create or authorize any change in the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, or increase the authorized number of shares directors of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015Group Company;
(d) to create, or issue issuance of any debenture new securities or any obligation instruments that are convertible intointo securities, excluding (i) any securities convertible intoissuance of the Preferred Shares under the Preferred Share Purchase Agreement, (ii) any option to purchase issuance of Ordinary Shares upon conversion of the Preferred Shares, and (iii) any issuance of Ordinary Shares (or subscribe for, options or warrants exercisable for, Shares of therefor) under employee equity incentive plans approved by the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement)Board;
(e) to purchase any amendment or redeem change of the rights, preferences, privileges or pay any dividend on any capital stock prior to powers of, or the Series A Preference Sharesrestrictions provided for the benefit of, the Series B Preference Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015Preferred Shares;
(f) any action by the Company to authorize, create or authorize the creation issue shares of any debt security (other than equipment leases class or bank lines of credit) unless such debt security has received the prior approval series of the Board, including Company having preferences superior to or on a parity with the approval of the Series A Director, the Series B Director and the Series D DirectorPreferred Shares;
(g) any action by the Company to increase reclassify any outstanding shares into shares having preferences or decrease priority as to dividends or assets senior to or on a parity with the size preference of the BoardPreferred Shares;
(h) any repurchase or redemption of any equity securities of the Company other than pursuant to approve any change the redemption right of the holders of Preferred Shares as provided in the business scope Restated Memorandum and Articles or activities contractual rights to repurchase Ordinary Shares from the employees, directors or consultants of the CompanyCompany upon termination of their employment or services;
(i) to take actions subject to other protective provisions to be set forth in the definitive agreements decisions in connection with the Series A financing, the Series B financing or the Series D financing;
(j) to approve and change any compensation package of the management initial public offering of the Company, including but not limited to the chief executive officerstock exchange, general managertiming, and valuation of initial public offering of the Company;
(j) appointment, removal and remuneration of senior management (including Chairman, CEO, COO, CFO) of any Group Company;
(k) the declaration and/or payment of any and all dividends on any securities of any Group Company;
(l) the repurchase by any Group Company of any outstanding securities and any other reduction of capital or similar process;
(m) any merger, consolidation, scheme of arrangement, recapitalization or sale of all or substantially all of the assets of any Group Company;
(n) any expenditure, any purchase and disposal of assets and businesses, or any purchase and disposal of assets and businesses worth, in the aggregate, more than RMB five million (RMB5,000,000), per transaction or in the aggregate in a fiscal year, by any Group Company;
(o) any transaction between the Company or any of its subsidiaries on the one hand, and any Related Party, on the other key employeehand;
(p) employment of any Related Party by any Group Company;
(q) any capital expenditures or any capital commitments (i) that are in excess of the amount of ten thousand U.S. dollars (US$10,000) per transaction or fifty thousand U.S. dollars (US$50,000) in the aggregate in a fiscal year; and (ii) that are outside annual budget approved by the Board;
(r) any non-ordinary course of transactions (i) that are in excess of the amount of RMB five million (RMB5,000,000) per transaction or in the aggregate in a period of 12 month; and (ii) that are outside annual budget approved by the Board
(s) incurrence of debt or assumption of any financial obligation or issue, assumption, provision of guarantee or creation of any liability for borrowed money exceeding the amount of RMB five million (RMB5,000,000) per transaction or in the aggregate;
(t) adoption or change of the treasury policy, any material accounting policy or the fiscal year of any Group Company;
(u) establishment of any subsidiary or affiliates and the signing of any shareholders agreement or joint venture agreement by any Group Company;
(v) appointment or change of the auditors;
(w) any purchase by any Group Company of equity securities of, or any securities convertible into equity securities of, any other company exceeding the amount of RMB five million (RMB5,000,000);
(x) the adoption of, or amendment to, any employee equity incentive plan of any Group Company;
(y) any change in the business plan or scope of principal business of any Group Company; and
(kz) to agree or undertake to do any approval of the foregoingbusiness plan or the annual budget of the Group Companies.
Appears in 1 contract
Protective Provisions. 10.1 Approval of Series A Preference Shares, Series B Preference Shares, Series D Preference Shares. (a) For so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 Shares and 808,835 at least five million (5,000,000) Series A Shares (subject to adjustments made as adjusted for share split, subdivision, consolidation, reorganization and the like events), in addition to any other vote or consent required elsewhere in the Memorandum and Articles or by applicable LawRecapitalizations) remain outstanding, the Company shall not, and Members of the Company shall procure that the Company and each of its Subsidiaries shall not (directly or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take any of the following actions (other than those in connection with a Non-Liquidation M&A) actions, either directly or indirectly by merger, consolidation, amendment to the Articles or otherwise, without first obtaining the prior vote or written consent of the holders of at least 50% a majority of the then outstanding Series D Preference Shares, the holders of at least 50% of the then outstanding Series B Preference Shares and the holders of at least 50% of the then outstanding Series A Preference SharesShares then outstanding, each voting separately as a single class.:
(i) cause or permit the redemption, repurchase or other acquisition, directly or indirectly, of shares of the Company other than (A) the Company’s Ordinary Shares that are being repurchased at a price not higher than the original purchase price pursuant to option agreements or restricted share purchase agreements between the Company and any employees, officers, directors, consultants or service providers or pursuant to a right of first refusal held by the Company and (B) a redemption effected by the Company in accordance with Article 13 or Article 16 of the Articles to allow for the conversion of Preference Shares into Ordinary Shares;
(ii) declare or take any action resulting in payment of dividends or distributions with respect to the share capital of the Company (other than redemptions and repurchases permitted under (a) to liquidate, dissolve or wind up the affairs of the Company, or effect any Liquidating Transactionabove);
(biii) to amend, alter, increase or repeal any provision of the Memorandum and Articles;
(c) to create or authorize the creation of or issue any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, or increase decrease the authorized number of shares of any class or series of the Company’s share capital;
(iv) amend or determine any provisions of the Memorandum or the Articles, or change any rights, preferences, privileges or restrictions applicable to the holders of Series A Shares, except if there is no resulting materially disproportionate adverse effect on the holders of Series A Shares; provided, however, that the increase or decrease of authorized shares of any class or series of the Company’s share capital (other than the Series A Shares) or the authorization and issue of a new senior or pari passu class or series of securities shall not be deemed to have a materially disproportionate adverse effect on the holders of Series A Shares; provided, further, that consent shall not be required in connection with a Qualified IPO in which Preference SharesShares are converted into Ordinary Shares pursuant to Article 16 of the Articles;
(v) authorize, designate, reclassify, amend or issue, or obligate the Company to do any of the foregoing with respect to, any class or series of equity securities, including any security exercisable for or convertible into any equity security, which is or will be senior to or pari passu with, the Series A Shares with respect to any rights, preferences or privileges or restrictions other than the Series B Preference Shares or and Series B-1 Shares and any warrant issued in connection with the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding of the holders of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders issuance of Series D B-1 Shares before the Company may enforce (and any paramount lien on, make a call on equity securities issued or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) to create, or issue issuable upon exercise of any debenture or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreementsuch warrant);
(evi) a voluntary dissolution or liquidation of the Company; or
(vii) authorize, enter into or agree to purchase a Deemed Liquidation Event (with the exception of an Approved Sale) or redeem Recapitalization.
(b) For so long as at least five million (5,000,000) Series A Shares (as adjusted for Recapitalizations) remain outstanding, the Company shall not take any of the following actions, either directly or pay indirectly by merger, consolidation, amendment to the Articles or otherwise, without first obtaining the approval of a majority of the Board, including at least two (2) Series A Directors:
(i) incur any dividend indebtedness over US$500,000 other than trade payables incurred in the ordinary course of business;
(ii) change the number of directors on the Board;
(iii) adopt the annual budget and executive bonus goals; or
(iv) incur any capital stock prior or product development expenditures over US$1,000,000 cumulative to any single company, product or project, except as may be set forth in a budget that was previously approved by a majority of the Board, including at least two (2) Series A Preference Shares, the Directors.
(c) For so long as at least five million (5,000,000) Series B Preference Shares or the Series D B-1 Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/servicesas adjusted for Recapitalizations) remain outstanding, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce shall not take any paramount lien onof the following actions, make either directly or indirectly by merger, consolidation, amendment to the Articles or otherwise, without first obtaining the approval of a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with the Memorandum and Articles after July 1, 2015;
(f) to create or authorize the creation of any debt security (other than equipment leases or bank lines of credit) unless such debt security has received the prior approval majority of the Board, including the approval Series B-1 Director (as defined in the Articles):
(i) amend or determine any provisions of the Memorandum or the Articles, or change any rights, preferences, privileges or restrictions applicable to the holders of Series A DirectorB-1 Shares, except if there is no resulting materially disproportionate adverse effect on the holders of Series B-1 Shares; provided, however, that the increase or decrease of authorized shares of any class or series of the Company’s share capital (other than the Series B Director B-1 Shares) or the authorization and issue of a new senior or pari passu class or series of securities shall not be deemed to have a materially disproportionate adverse effect on the holders of Series D DirectorB-1 Shares; provided, further, that consent shall not be required in connection with a Qualified IPO in which Preference Shares are converted into Ordinary Shares pursuant to Article 16 of the Articles;
(gii) to increase sale or decrease the size disposition of the Boardwhole or a substantial part (more than 25% of the assets on a consolidated basis) of the business, goodwill or assets of the Company or any material subsidiary of the Company through sale, merger, acquisition, consolidation, or reorganization involving a change of control of the company in which the consideration for the Company taken as a whole is less than US$700,000,000 (less any required withholding, holdbacks or escrows);
(hiii) to approve any change in the business scope a voluntary dissolution or activities liquidation of the Company;
(iv) change or expansion of the business scope of the Company;
(v) any acquisition of or any investments in entities or businesses outside of the existing business scope of the company or any acquisition involving consideration in excess of US$20,000,000;
(vi) cause or permit the redemption, repurchase or other acquisition, directly or indirectly, of shares of the Company other than (A) the Company’s Ordinary Shares that are being repurchased at a price not higher than the original purchase price pursuant to option agreements or restricted share purchase agreements between the Company and any employees, officers, directors, consultants or service providers or pursuant to a right of first refusal held by the Company and (B) a redemption effected by the Company in accordance with Article 13 or Article 16 of the Articles to allow for the conversion of Preference Shares into Ordinary Shares; or
(vii) authorize, enter into or agree to a Deemed Liquidation Event (with the exception of an Approved Sale) or Recapitalization.
(d) For so long as at least five million (5,000,000) Series B-1 Preference Shares (as adjusted for Recapitalizations) remain outstanding, the Company shall not take any of the following actions, either directly or indirectly by merger, consolidation, amendment to the Articles or otherwise, without first obtaining the approval of: (i) to take actions subject the extent there are six (6) or more Directors sitting on the Board, five (5) Directors and (ii) to other protective provisions to be set forth in the definitive agreements in connection with extent there are five (5) or fewer Directors sitting on the Board, a majority of the Board including at least one (1) of the Series A financingB-1 Director, the Series B financing Ordinary Share Director or the Independent Director:
(i) approval of any related party transaction (or series of related transactions) involving consideration or value in excess of US$20,000; provided that the interested director(s) (if any) shall be required to disclose their interest therein and abstain from deliberation and voting therefor (but shall be counted for the purposes of quorum); provided further that if the previous proviso is not met, such transaction(s) must be approved by a majority of the Board, including the Series D financingB-1 Director if such Director is not an interested director;
(jii) to approve incur additional indebtedness, commitments or guarantees of indebtedness in excess of US$5,000,000;
(iii) approval of any new option plans or other equity incentive arrangements or grant of incentive options;
(iv) approval of annual budget or material amendment thereof;
(v) any single expenditure in excess of US$1,000,000 or expenditures in excess of US$5,000,000 in any 12-month period which are not included in an approved annual budget;
(vi) determination of timing, venue and change valuation of any compensation package IPO of the management Company other than a Qualified IPO; or
(vii) appointment of the Company, including but not limited to the chief executive officer, general manager, and any other key employee; and
(k) to agree or undertake to do any of the foregoing’s corporate officers.
Appears in 1 contract
Protective Provisions. 10.1 Approval of Series A Preference SharesIn addition to such other limitations as may be provided in the Articles, Series B Preference Shares, Series D Preference Shares. For for so long as Bertelsmann, Sumitomo and BlueFocus respectively holds no less than 448,801 Shares, 437,629 any Preferred Shares and 808,835 Shares (subject to adjustments made for share split, subdivision, consolidation, reorganization and the like events), in addition to any other vote or consent required elsewhere in the Memorandum and Articles or by applicable Laware outstanding, the Company shall not, and Members following acts of the Company shall procure that require the prior written approval of the Preferred Majority, or the written approval of more than fifty percent (50%) of the directors of the Board (including the approval of each Investor Director), as the case maybe. For the purpose of this Section 8, the term “Company” means, the Company itself as well as any and each of its Subsidiaries shall not (directly or by amendment, merger, consolidation, amalgamation, scheme of arrangement or otherwise) take any all the subsidiaries of the following actions Company (including but not limited to the other than those in connection with Group Companies), to the extent and where applicable. Notwithstanding anything to the contrary contained herein, where any such action requires a Non-Liquidation M&A) without the prior vote special resolution or written consent ordinary resolution of the holders of at least 50% shareholders in accordance with the Companies Law (Revised) of the then outstanding Series D Preference SharesCayman Islands and if the shareholders vote in favor of such act but the approval of the Preferred Majority has not yet been obtained, the holders of the Preferred Shares who vote against such act at least 50% a meeting of the then outstanding Series B Preference Shares and shareholders in aggregate shall have the holders voting rights equal to the aggregate voting power of at least 50% all the shareholders who voted in favor of the then outstanding Series A Preference Shares, each voting separately as a single classsuch act plus one.
(a) to liquidate, dissolve any issuance or wind up the affairs sale of any equity or debt securities of the Company, excluding any issuance of Class A Ordinary Shares upon conversion of the Preferred Shares (including, without limitation, the creation, issuance, sale or effect sponsorship of any Liquidating Transactioncryptocurrency, decentralized application tokens, protocol tokens, blockchain-based assets or other cryptofinance coins, tokens or similar digital assets by the Company, an officer of the Company or any direct or indirect majority-owned subsidiary of the Company);
(b) to amendany amendment or change of the rights, alterpreferences, privileges or powers of, or repeal any provision the restrictions provided for the benefit of the Memorandum and ArticlesPreferred Shares;
(c) to create any action that authorizes, creates or authorize the creation of or issue issues any other security convertible into or exercisable for any equity security, having rights, preferences or privileges senior to or on parity with the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares, or increase the authorized number class of shares of the Series A Preference Shares, the Series B Preference Shares or the Series D Preference Shares or do any act which has the effect of diluting or reducing the effective shareholding capital of the holders of Company having preferences superior to or on a parity with the Series A Preference Preferred Shares, the Series B Preference Shares or the Series D Preference Shares, provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Shares held by BlueFocus representing the unpaid Residual Amount (if any) in accordance with in the Memorandum and Articles after July 1, 2015;
(d) any action that reclassifies any outstanding shares into shares having preferences or priority as to create, dividends or issue of any debenture assets superior to or any obligation convertible into, any securities convertible into, any option to purchase or subscribe for, or warrants exercisable for, Shares on a parity with the preference of the Company (other than grant stock options to employees or consultant as ESOP pursuant to this Agreement)Preferred Shares;
(e) any act that repurchases, redeems or retires any of the Company’s voting securities (excluding (i) pursuant to purchase or redeem or pay any dividend on any capital stock prior contractual rights to the Series A Preference Shares, the Series B Preference repurchase Ordinary Shares or the Series D Preference Shares (other than stock repurchased from former employees or consultants in connection with the cessation of their employment/services, at the lower of fair market value or cost), provided that, no vote or written consent under this Section shall be required from the Holders of Series D Shares before the Company may enforce any paramount lien on, make a call on or forfeit any Preferred Shares held by BlueFocus representing employees, directors or consultants of the unpaid Residual Amount Company or its subsidiaries upon termination of their employment or services, or pursuant to the exercise of a contractual right of first refusal held by the Company, or (if anyii) the redemption entitled by the holders of relevant class or series of shares as set forth in accordance with the Memorandum and Articles after July 1, 2015Articles);
(f) to create any increase or authorize decrease in the creation of any debt security (other than equipment leases authorized share capital or bank lines of credit) unless such debt security has received the prior approval registered capital, as applicable, of the Board, including the approval of the Series A Director, the Series B Director and the Series D DirectorCompany;
(g) to increase or decrease the size any amendment of the BoardCompany’s Memorandum and Articles of Association or other charter documents of the Company;
(h) to approve the declaration or payment of a dividend or other distributions on any change in the business scope or activities securities of the Company;
(i) any increase or decrease of the authorized size of the board of directors of the Company, or any amendment of the rules to take actions subject to other protective provisions to be set forth in appoint or remove the definitive agreements in connection with directors of the Series A financing, the Series B financing or the Series D financingCompany;
(j) to approve and change any compensation package the liquidation, dissolution or winding up of the management Company;
(k) any consolidation, merger, corporate reorganization, transaction or series of transactions of the founder, in which in excess of fifty percent (50%) of the Company’s voting power is transferred or in which all or substantially all the assets of the Company are sold;
(l) the sale of all or substantially all of any of the Company’s assets, or any material asset or undertaking of the Company;
(m) any Transfer of the shares or equity interest of the Company directly or indirectly held by the Founder, or dispose of or dilute the Company’s interest, directly or indirectly, in any of its subsidiaries, unless otherwise provided herein;
(n) any establishment, alteration or termination of any profit sharing scheme or any employee share option or share participation schemes, or any grant of options or warrants under such scheme;
(o) incurrence of debt or assumption of any loan, facility or other financial obligation from a third party, or issue, assumption, provision of guarantee, charge, lien or indemnity warranty in favor of a third party, or creation of any liability (including without limitation any off-balance-sheet liability or contingent liability) by the Company, in excess of RMB3,000,000 in the aggregate in any consecutive twelve (12) months period outside the annual budget of the Company, or extension of loan by the Company to any third party in excess of RMB3,000,000 in the aggregate in any consecutive twelve (12) months period outside the annual budget of the Company, other than those in the ordinary course of business;
(p) creation of any liability on any patent, copy right, trademark, or any other intellectual property right of the Company;
(q) the initial public offering of any of the Shares or other equity or debt securities of the Company (or as the case may be, the shares or securities of the relevant entity resulting from any merger, reorganization or other arrangements made by or to the Company for the purposes of public offering);
(r) any equity investments in any other person or entity (including any direct or indirect establishment or any acquisition of any subsidiary);
(s) approval or removal of the auditor of the Company;
(t) any material change to the business of the Company, including but not limited entering new lines of business outside the existing business and exiting the current business;
(u) termination or any material amendment to the chief executive officer, general manager, and any other key employee; andRestructuring Documents (as defined in the Share Purchase Agreement);
(kv) to agree settlement of litigation, arbitration or undertake other disputes involving value of no less than US$500,000 in a single transaction or no less than US$3,000,000 in the aggregate in any consecutive twelve (12) months;
(w) appointment or removal of the Chief Executive Officer, Chief Financial Officer, Chief Technology Officer, Chief Operating Officer;
(x) approval or material amendment (by more than 30% in any fiscal year) of the annual budget; or
(y) agreement or commitment by the Company to do any of the foregoing.
Appears in 1 contract